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1. INTRODUCTION 
The literature concerning the effects of macrophages on the immune response is 
already large and growing rapidly. Macrophages seem to be involved in almost every 
phase of the immune response. Not only are they important as effector cells in their 
own right, but there is now a wealth of information suggesting macrophages may, 
through a combination of suppressing and enhancing effects, play an important role in 
regulating the immune response. Evidence obtained both in vivo and in vitro supports 
the concept of macrophages as immunoregulatory cells. We shall review here the 
available in vivo and in vitro evidence for augmentation and suppression of immune 
response by macrophages, and will also suggest how macrophages may play a role as 
effector cells in T cell suppression and antigenic competition. 
Many of the in vitro experiments, on which important conclusions have been based, 
have compared the results obtained in assay systems using cell populations depleted 
of macrophages to those obtained using cell populations containing, or highly enriched 
for, macrophages. Before discussing the details of these experiments, it is important 
to note that there are problems with interpreting such data. 
There is virtually no way to prepare cell populations completely free of macro- 
phages. None of the available methods have been shown to reduce the proportion of 
macr0phages below 0.1 per cent, and this may not be sufficient to rule out the role of 
very small numbers of macrophages as auxiliary cells for the induction of immune 
responses. Most of the macrophage depletion procedures are based on adherent or 
phagocytic properties of macrophages. Petri dish adherence (Mosier, 1967) allows 
separation of the cells into two populations which can be tested alone or after 
recombination. The resultant populations, however, are by no means pure and the 
degree of depletion of macrophages is not as good as that achieved by other 
techniques. Passage of lymphoid cells over adherence columns of nylon wool (Julius 
et al., 1973), rayon cotton (Kirchner et al., 1974b), glass beads (Shortman, 1968), or 
Sephadex G-10 (Ly and Mishell, 1974) allows rather good depletion of adherent cells. 
However, since B cells are adherent, albeit less than macrophages, those procedures 
most effective in depleting adherent cells must of necessity deplete a certain propor- 
tion of the B cells. In fact, a procedure based on this principle has been described to 
obtain a purified population of T cells simply by depleting all of the adherent cells 
(Julius et al., 1973). Since, however, as many as 80 per cent of the cells are lost when 
performing such procedures, it is obvious that even some T cells are depleted. In 
addition to the separation procedures based on the adherent properties of macro- 
phages, incubation of cells with powdered iron to allow phagocytic cells to ingest the 
iron particles, and then passage of the cells through a strong magnetic field to obtain a 
population free of phagocytes (iron and magnet technique), has been a useful 
technique to obtain a phagocyte-depleted population (Kirchner et al., 1974b). 
However, since the percentage of the cells recovered (50-60 per cent of normal spleen 
cells) is routinely lower than the percentage of cells which are non-phagocytic, it is 
clear that even this depletion technique is not entirely selective for macrophages. 
Another approach to the problem of obtaining purified cell populations has been the 
551 
JPTA Vol. 2, No. 3--H 
552 J. RONALD OEHLER et al. 
use of procedures wherein lymphocytes are allowed to rosette with heterologous 
erythrocytes and then placed over a Ficoll-Hypaque density gradient which separates 
the rosette-forming cells (T cells) from the non-rosette-forming cells. The use of such 
procedures has been reported in guinea pigs (Rosenstreich and Oppenheim, 1976) and 
humans (West et al., 1976). Combinations of adherence depletion techniques and 
enrichment techniques such as just described seem likely to yield the purest popu- 
lations. In addition to the above techniques, several substances and compounds have 
been reported to be selectively toxic for macrophages. Silica and carrageenan (Allison 
et al.,  1966) have been used in v ivo  and in v i tro to deplete macrophage activity. 
Trypan blue (Hibbs, 1974) has been reported to be similarly effective. Finally, there 
are several reports of the use of 'specific' anti-macrophage sera and complement to 
kill macrophages (Feldmann and Palmer, 1971; Gorczynski, 1976). Unlike mouse T 
cells which express allelic forms of theta and Ly antigen on their surfaces, allelic 
forms of macrophage surface antigens have not been identified in any species thus far. 
Therefore, the antisera must be produced in heterologous species and attempts made 
to render them specific, by extensive absorption procedures with cell populations free 
of macrophages. However, as is apparent from the above discussion, macrophage-free 
populations are difficult to prepare, and further, if readily available, they would largely 
obviate the need for anti-macrophage sera. The difficult problems in this area have 
been reviewed by Leibovich and Ross (1975). 
Preparation of p u r e  macrophage populations is also difficult. In rodents and guinea 
pigs, a population enriched for macrophages can be obtained by washing out the 
peritoneal cavity, and many investigators refer to peritoneal exudate cells and 
macrophages interchangeably. Mice normally have 2-3 x 10 6 macrophages resident in 
the peritoneal cavity which can be washed out. It is important to note, however, that 
the resultant population is heterogeneous, consisting of about 60 per cent lym- 
phocytes, 35 per cent macrophages, and occasional mast and other cells (Edelson and 
Cohn, 1976). If irritating agents such as light mineral oil, 10 per cent proteose peptone 
broth, or thioglycolate are placed in the peritoneal cavity, a sterile peritonitis 
develops. Initially there is an influx of neutrophils, maximally present about 48 hr 
after injection of the irritant. By 72-96 hr, most of the neutrophils have disappeared 
and macrophages make up the majority of the cells in the peritoneal exudate (PEC). 
Shevach (1976) reported that in guinea pigs, 3 days after i.p. injection of light mineral 
oil, the PEC consisted of 75 per cent macrophages, 10 per cent neutrophils and 15 per 
cent lymphocytes. By allowing such PEC to adhere to glass slides for 3hr and 
washing off the nonadherent cells, a population consisting largely of macrophages and 
neutrophils remained (Lipsky and Rosenthal, 1973). Neutrophils, unlike macrophages, 
do not survive overnight incubation in media at 37 ° (Edelson and Cohn, 1976). Thus, 
Lipsky and Rosenthal (1973) reported that after overnight incubation, the adherent 
PEC remaining on the slides after vigorous washing were 99 per cent pure macro- 
phages. Erb and Feldmann (1975a) used similar adherence techniques to purify PEC 
from mice. In addition, they treated the adherent PEC with both an anti-T cell and 
anti-B cell serum and complement followed by irradiation with 200 R. They reported 
that after thorough washing the macrophages were 99.7 per cent pure. Katz and Unanue 
(1973) used similar procedures in mice, injecting 1 ml of 10 per cent proteose peptone 
broth to induce the PEC. After 3 days, 8-15 x 106 PEC could be obtained which were 
85 per cent pure macrophages. When such mice were irradiated with 660 R 24 hr prior 
to harvesting, only 4 x 106 PEC were recovered but 98 per cent were macrophages. In 
humans, PEC are obviously not readily available. However, Rode and Gordon (1974) 
could obtain essentially pure populations of monocytes from human peripheral blood 
leukocytes (PBL) separated from the red blood cells (RBC) with a Ficoll-Hypaque 
gradient, by allowing the PBL to adhere to glass Petri dishes for 8 days and 
vigorously washing off all remaining nonadherent cells. It should be noted that mosi 
of the procedures used to induce macrophages in the peritoneal cavity, or to isolate 
the macrophages, cause activation and other functional changes. For example, 
adherence to a surface results in increased protein synthesis and increased enzyme 
production by macrophages (Bodel et al., 1977). 
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Whatever procedures are used to prepare macrophage-depleted or -enriched cell 
populations, it is obvious that the purity of the resultant population must be docu- 
mented. Several methods are available for identification of macrophages and mono- 
cytes, but none are entirely satisfactory. The ingestion of various substances such as 
latex particles, colloidal carbon and heterologous erythrocytes has been used to 
identify phagocytic cells. In addition, histochemical staining techniques (Goldstein 
and Blomgren, 1973), particularly for nonspecific esterase (Yam et al., 1971), are now 
widely used to identify macrophages. However, it is possible that even these methods 
may be fallible. Nathan et al. (1976) have expressed concern that a population of cells 
that they have isolated from the peritoneal exudates of mice pretreated with Bacille 
Calmette-Guerin (BCG) which have strong anti-proliferative effects on tumor cells in 
vitro, although adherent and staining positive for esterase, may be non- or poorly 
phagocytic under the conditions they used. They have been reluctant to call these 
cells macrophages and thus raise the question of whether cells other than macro- 
phages and monocytes may stain positive for nonspecific esterase. Confirmatory 
reports of a discrete population of esterase positive, non-phagocytic cells, however, 
have not yet appeared. Enumeration of macrophages by any of the procedures is 
complicated by the fact that in any cell population there are not only mature 
macrophages and monocytes but also macrophage and monocyte precursors which 
may not be readily identifiable. These cells, although less adherent (Cline and Sumner, 
1972), much less susceptible to anti-macrophage sera and complement (Virolainen et 
al., 1972), and probably non-phagocytic, can mature during in vitro culture and 
function as macrophages even after the most efficient depletion procedures based on 
these functional properties. Many of these problems have been extensively discussed 
in a recent book (Bloom and David, 1976). 
Macrophages appear to be a heterogeneous group of cells, both functionally and 
morphologically. At the present time it is not clear whether the heterogeneity is 
simply a result of different levels of maturation or whether there are in fact distinct 
subpopulations of macrophages which can be identified on the basis of certain cell 
surface or functional characteristics'. During maturation from promonocyte through 
monocyte and immature macrophage to mature macrophage, there are many changes 
in their functional characteristics. Territo and Cline (1976) have provided evidence 
that the frequency of cell division decreases as the cells mature, while other charac- 
teristics such as phagocytic activity, glass adherence, microbicidal activity, surface 
receptors for immunoglobulin and the ability to interact with lymphoid cells in various 
immune reactions, generally increase. 
Macrophages or monocytes from different sources display divergent characteristics. 
Bennet (1966) has shown that when macrophages from different tissue sources were 
isolated and cultured in vitro, their rate of attachment to glass as well as their mitotic 
rate in culture varied. Based on these features, Bennet described three categories of 
macrophages: peritoneal and peripheral blood macrophages that attached rapidly and 
had a low mitotic rate; bone marrow, spleen and liver macrophages that spread slowly 
and had a high mitotic rate; and alveolar macrophages that spread rapidly and had a 
high mitotic rate. Nitulescu and F6rster (1976) reported that there were antigenic 
differences between the alveolar and peritoneal macrophages in rats. Walker (1967a) 
has also discussed the differences in functional activity between macrophages from 
various sources. He noted that peritoneal macrophages had a higher bactericidal 
activity than did alveolar macrophages and in addition that they had higher Fc 
receptor avidity. Furthermore, peritoneal macrophages responded well to chemotactic 
agents and were very efficient at rendering antigen immunogenic, while alveolar 
macrophages had low activity in these tests. Similarly, Boumsell and Meltzer (1976) 
have noted differences in the chemotactic response of blood monocytes and peri- 
toneal macrophages to lymphocyte and complement-derived chemotactic substances 
with regard to both time-course and dose response. Hence, there is evidence that 
macrophages from different tissues may vary considerably in their functional charac- 
teristics. Whether this is due to stage of maturation or to subpopulation distribution is 
not clear. 
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Macrophages from a single tissue source may also be heterogeneous in terms of 
their surface characteristics and their functional reactivity. Rhodes (1975) found that 
there was marked variability in the avidity of the Fc receptors among guinea pig 
peritoneal macrophages.  If the macrophages were induced with an inflammatory 
agent, there was a six-fold increase in the proportion of macrophages with high 
avidity Fc receptors.  Heterogenei ty  in macrophage function has been noted by a 
number of investigators and has recently been reviewed by Walker (1976a). Basically, 
two types of observations suggested there may be functional subclasses of macro- 
phages: (i)  only a certain percentage of macrophages performed certain functions 
under similar conditions (such as phagocytosis of bacteria or erythrocytes) ,  or (ii) 
macrophage populations which were fractionated based on their density or size, could 
be identified on the basis of various functional characteristics. Walker (1976b) used a 
discontinuous Ficoll gradient to fractionate rabbit peritoneal exudate cells into five 
subpopulations. Several different functional tests were then performed with the cells 
from each fraction. He found that binding of ~25I-T2 antigen was greatest in fraction i 
(least dense) while binding through the Fc receptor  was greatest in the denser 
fractions 3 and 4. In addition, Walker fractionated rat peritoneal exudate cells from 
animals that had been immunized with a chemically induced tumor (plus BCG) and 
found that the cytotoxic reactivity of the macrophages resided predominately in two 
fractions. Similarly, differences in the size of macrophage effector  cells were noted by 
Holden et al. (1976) in studies of the growth inhibitory activity of macrophages 
isolated from murine sarcoma virus-induced tumors. There were two functional 
subpopulations with different cell sizes (as determined by sedimentation velocity at 
l g). 
All of these studies, however,  are complicated by the fact that different methods of 
induction were used for harvesting macrophages and the cells may exhibit various 
levels of activation. In addition, the process of activation may call in a specific 
subpopulation of cells or, as suggested recently by Bomford and Olivotto (1975) and 
Woodruff  et al. (1975), the activation process may cause macrophage precursors to 
differentiate into mature cells. Unfortunately at this time there is not enough in- 
formation on subpopulations of macrophages from any one source to determine 
whether  different functions will regularly be associated with particular macrophage 
subpopulations. 
In all, it is apparent that dogmatic statements concerning the absolute requirement for 
macrophages,  or the lack thereof  for various immune responses,  require careful 
documentat ion to be at all convincing. However ,  despite the above problems, it has 
still been possible to extensively study the role of macrophages in enhancing and 
suppressing immune responses,  and evidence has been presented that macrophages 
play a vital role in regulating the immune response. 
2. E N H A N C E M E N T  OF T H E  IMMU N E R E S P O N S E  
BY M A C R O P H A G E S  
Macrophages have been shown to enhance almost every  phase of the immune 
response. For  many immune responses generated in vitro, there appears to be an 
absolute requirement for  macrophages.  This, of course, does not prove that macro- 
phages are required in vivo or, if they are required, that they perform the same 
function in vivo as they do in vitro. When lymphocytes  are cultured without 
macrophages,  the viability after  4-5 days under some conditions is lower than when 
macrophages are present (Chen and Hirsch, 1972; Bevan et al., 1974). In contrast,  
there is little or no evidence that macrophages enhance the viability of lymphocytes  in 
vivo. Thus, it would seem that enhancing effects of macrophages on the immune 
response in vitro, which result only  from the improvement  of lymphocyte  viability, 
may have limited relevance in vivo. One way to prevent  such problems would be to 
p e r f o r m  in vitro investigations under optimal tissue culture conditions which are not 
substantially improved by the addition of macrophages.  In vivo experiments on the 
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role of macrophages in enhancing immune responses also have problems. Obser- 
vations made in vivo occasionally raise as many questions as they answer. Subclinical 
infections or fluctuations of hormone levels may affect in vivo experiments in ways 
that would be difficult to predict. However, with a combination of in vivo obser- 
vations, and in vitro experiments designed to dissect and explain the results obtained 
in vivo, meaningful interpretations may be suggested. In this section we shall discuss 
the evidence that macrophages can enhance immune response in vivo and then we 
shall discuss the evidence obtained in vitro as possible explanations for the in vivo 
findings. Recent concepts regarding the mechanisms of the enhancing effects of 
macrophages, including some of the current concepts of antigen presentation, will be 
reviewed. 
2.1. ENHANCEMENT OF THE IMMUNE RESPONSE IN VIVO 
There is considerable evidence that macrophages can enhance the immune response 
in vivo (Mitchison, 1969; Klaus, 1974; for reviews see Unanue, 1972; Oppenheim and 
Seeger, 1976). This is supported by many experiments in which injection of soluble 
protein antigen bound to macrophages (by exposure to live macrophages in vitro or in 
vivo) has resulted in stronger immune responses in experimental animals than has 
injection of equivalent quantities of free soluble antigen. In addition, there is evidence 
that certain immunodeficient states are a result of an incompetent reticuloendothelial 
system (Carter and Rector, 1972; Hardy et al., 1973; Blaese, 1975). 
Both humoral and cellular responses have been shown to be enhanced by injection 
of antigens bound to macrophages (Unanue, 1972, Oppenheim and Seeger, 1976). 
Routinely, macrophages have been washed after exposure to radiolabeled soluble 
antigen and then injected into the host. The amount of antigen injected with the 
macrophages has been determined by the radioactivity of the injected cells. With 
some exceptions (to be discussed below), the response was ten- to a thousand-fold 
higher on a per microgram basis when the antigen was injected bound to macrophages 
(Mitchison, 1969; Klaus, 1974). Other cells such as fibroblasts can bind approximately 
the same amount of soluble antigen as macrophages, but there is general agreement 
that antigens injected bound to fibroblasts fail to augment strong immune responses 
(Mitchison, 1969; Klaus, 1974). As has been found with other macrophage functions, 
the ability to enhance immunogenicity is radioresistant (Unanue, 1972). However, 
viable macrophages are required. Mitchison (1969) has shown that antigen transferred 
on dead macrophages was no more immunogenic than antigen injected alone. Also, 
the ability of the transferred cells to interact with host cells is required. Macrophages 
in Millipore chambers implanted into the peritoneal cavities of mice did not enhance 
immunogenicity (reviewed by Unanue, 1972). 
Although many soluble antigens are more immunogenic when transferred bound to 
macrophages, some are as immunogenic when injected alone. The ability of macro- 
phage-bound antigen to enhance immunogenicity has been shown to be inversely 
related to the ability of macrophages to clear the antigen from the serum in vivo 
(reviewed by Unanue, 1972). Keyhole limpet hemocyanin (KLH) was taken up very 
well by macrophages in vivo. Preincubation with macrophages in vitro did not 
enhance the response to it (Unanue, 1969). Presumably when such antigens are 
inoculated in soluble form, they are rapidly bound to tissue macrophages and are thus 
presented to the immune system in the same form as when they are bound to 
macrophages in vitro. On the other hand, human serum albumin (HSA) was phagocy- 
tized poorly by murine macrophages in vivo, and preincubation of HSA with macro- 
phages in vitro increased the resultant antibody response about one thousand fold 
when compared to equal microgram quantities of free HSA (Mitchison, 1969). In 
contrast to free soluble antigen, macrophage-bound antigen has not been shown to 
induce tolerance (Unanue, 1972). 
In addition to enhancement of a humoral or cellular immune response to antigen, 
macrophages can influence the type of response elicited. In guinea pigs, Oppenheim 
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and Seeger (1976) have shown that small doses of tetanus toxoid (0.1/zg), when bound 
to macrophages and given either intradermally or intracardiacly, induced delayed 
hypersensitivity type responses to subsequent challenge. In contrast, soluble antigen 
given in the same dose, schedule and routes resulted in immediate Arthus reactions, 
indicating high levels of circulating antibody. Further, two sequential injections of 
macrophage-bound tetanus toxoid resulted only in stronger delayed hypersenstivity. 
Boosting with tetanus toxoid alone, on the other hand, resulted in high levels of 
circulating antibody 2 weeks later (Oppenheim and Seeger, 1976). Thus, in some 
systems the use of macrophage-bound antigen for immunization results not only in an 
enhanced response but also in a response qualitatively different from that obtained 
with free soluble antigen. 
Finally, many of the immunodeficiencies of newborn animals appear to be asso- 
ciated with the immaturity of the mononuclear phagocytes. Neonatal mice responded 
very poorly to sheep erythrocytes when compared to adult animals (Argyris, 1968). 
However, the antibody response could be augmented considerably if the newborn 
mice were reconstituted with adult peritoneal exudate cells 2 days before im- 
munization. Since mouse spleen cells have been shown to contain antigen sensitive 
cells 24 hr after birth (Carter and Rector, 1972), the deficiency in neonatal mice would 
not appear to be in this population of cells. Furthermore, adoptive transfer studies of 
neonatal and adult mouse spleen cells into X-irradiated recipients also suggested that 
newborns lacked ceils needed to process the antigen, and that these cells were 
radioresistant, indicating that they might be macrophages (Carter and Rector, 1972). 
Hardy et al. (1973) found that the antibody response in mice to sheep erythrocytes as 
well as to Shigella paradysentheria was not evident until 3-5 days after birth. In 
exploring the role of the macrophage, they found the PEC from neonatal mice 
preincubated with Shigella antigen were unable to induce an antibody response in 
adult mice; while the use of PEC from adult mice led to significantly higher titers of 
antibody in the recipients. From this they concluded that the macrophages from 
newborn mice were incapable of taking up and processing the Shigella antigen 
sufficiently to induce a detectable antibody response. Blaese (1975) performed studies 
on the antibody response to several antigens in newborn rats and found that the 
response of the animal depended on the type of antigen used for immunization. Rats 
18 hr old did not respond to sheep or burro erythrocytes, KLH or type III pneumo- 
coccal polysaccharide, but responded fairly well to killed Brucella abortus. If the 
sheep erythrocytes given to the neonate were mixed with unfractionated PEC or 
macrophage-enriched PEC from adults, there was a strong antibody response. Anti- 
body responses to KLH or burro erythrocytes could be induced in neonates in a 
similar fashion. It is of interest that Brucella as well as several other macrophage 
activators, when injected into newborn rats with the immunogen, were able to 
substitute for adult macrophages, presumably by activating the resident macrophages. 
Finally, by inoculating neonates with high doses of antigen it was relatively easy to 
induce tolerance to that antigen. Blaese (1975) suggested that this was also due to the 
immaturity of the macrophages in these animals, since the rats did not become 
tolerant when antigen was injected with adult macrophages. 
2.2. ENHANCEMENT OF THE IMMUNE RESPONSE IN VITRO 
In vivo experiments such as those described above have shown that macrophages 
could enhance and, in some cases, qualitatively alter the expression of the immune re- 
sponse. Although demonstrating the significance of macrophages in eliciting various 
immune responses, such in vivo experiments do not allow definition of the 
mechanisms of action. Unlike experimental models of T cell or B cell deficient 
animals (e.g. the nude mouse or bursectomized chicken), no model of complete and 
selective macrophage deficiency is readily available. Macrophages are functionally 
radioresistant so even in adoptive transfer experiments, resident macrophages may 
participate in the immune response. Agents which are considered to be selective.ly 
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toxic for macrophages such as carrageenan, silica (Allison et al., 1966), or trypan blue 
(Hibbs, 1974) are less than totally effective (Sawicki and Catanzaro, 1975). In addition, 
in in vivo experiments, it is usually difficult to identify the phase in the immune 
response during which macrophages are required. For example, in the study of 
Schwartz and Leskowitz (1969), in which simultaneous injection of carrageenan with 
antigen temporarily suppressed delayed hypersensitivity responses in guinea pigs, one 
cannot distinguish between the effect of carrageenan on macrophages involved in the 
afferent or the efferent limb of the response. In contrast, in vitro experiments allow 
more precise dissection of the site of action of macrophages. 
2.2.1. The M a c r o p h a g e  Requ i remen t  f o r  the Generat ion o f  A n t i b o d y - P r o d u c i n g  Cells 
In Vitro 
There are several techniques for generating antibody responses in a totally in vitro 
environment. One of the most commonly used techniques is the Mishell-Dutton 
culture system (Mishell and Dutton, 1966), followed by a Jerne plaque assay (Jerne 
and Nordin, 1963). Mosier (1967), using a modification of such a system, was one of 
the first investigators to show a requirement for two distinct cell types for the in vitro 
primary generation of antibody-forming cells (AFC) in response to sheep erythrocytes 
(SRBC). After separating murine spleen cells on the basis of adherence to a glass 
Petri dish, neither the nonadherent nor the adherent fraction could generate antibody- 
forming cells. However, the recombined fractions responded as well as the un- 
fractionated population. These results have been verified with antibody production to 
all heterologous RBC tested (Katz and Benacerraf, 1972; Pierce, 1969, 1973; Feld- 
mann and Palmer, 1971; Sjobert et al., 1972; Shortman and Palmer, 1971; Shortman et 
al., 1970; Cosenza et al., 1971; Mosier, 1968; McIntyre and Pierce, 1973). In addition, 
the macrophage requirement for AFC production has been demonstrated using 
hapten-protein conjugates (Feldmann et al., 1974) or synthetic soluble copolymers 
(Pierce et al., 1974; Kapp et al., 1973) as antigens. IgM, IgG and IgA plaque-forming 
responses have all been shown to require macrophages in vitro (Pierce, 1973). 
Although early reports suggested that the secondary response was not dependent 
upon macrophages (Pierce, 1969; Katz and Unanue, 1973), it has now been shown that 
both primary and secondary responses require adherent and phagocytic cells (re- 
viewed by Oppenheim and Rosenstreich, 1976). Whether other cells without known 
immunologic effects can substitute for macrophages in these in vitro responses is not 
entirely clear. Katz and Unanue (1973) have reported that DNP-KLH bound to 
fibroblasts could induce an AFC response comparable to that induced with DNP- 
KLH bound to macrophages when added to nonadherent DNP-KLH-primed mouse 
spleen cells in a Mishell-Dutton culture system. Similarly, MSller et al. (1976) have 
recently shown that fibroblasts could reconstitute the primary AFC response of 
nonadherent mouse spleen cells in a Mishell-Dutton culture system with SRBC. In 
these cases, however, it is likely that residual macrophages left in the spleen 
preparations after the macrophage-depletion procedures were responsible for inducing 
the responses observed and that the fibroblasts simply amplified the response by 
improving the culture conditions by a nonspecific feeder effect. Be that as it may, in 
addition to adherent cells and B cells, T cells are required for the generation of AFC 
to the above antigens in vitro. In contrast, another class of antigens which can 
stimulate AFC in vitro in the absence of T cells (T-independent antigens) have until 
recently been considered macrophage independent (Feldmann et al., 1974; Mosier et 
al., 1974; Feldmann, 1972a; Lemke et al., 1975). These findings suggested that the 
primary role of macrophages in enhancing AFC production to T-dependent antigens 
might be related to the requirement for T cells. However, recent reports (Chused et 
al., 1976; Lee et al., 1976; Pike and Nossal, 1976), showing that some T-independent 
antigens do in fact require macrophages, do not support this notion. Polyclonal 
antibody responses to B cell mitogens such as LPS (Lemke et al., 1975) which are also 
T-independent, have not (with one exception) been shown to require macrophages in 
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vitro (Oppenheim and Rosenstreich, 1976; Rosenstreich and Oppenheim, 1976). The 
exception is a report by Kragnoff et al. (1974) which showed that the LPS-induced 
proliferative response of B cells from the Peyer's patches of nude mice required 
either 2-mercaptoethanol or macrophages. However, in this case, T cells were also 
required, suggesting this situation was unusual if not unique. 
2.2.2. The Requ i remen t  f o r  Macrophages  [or  T Cell Responses  In Vitro 
Consistent with the enhanced immunogenicity afforded by macrophage-bound 
antigen in induction of delayed hypersensitivity responses in vivo (Oppenheim and 
Seeger, 1976) are experiments showing that macrophages are required for the genera- 
tion of T cell responses in vitro. T cell proliferative responses in mixed leukocyte 
culture (MLC) were found to require macrophages in mice (Bevan et al., 1974) and 
humans (Jones, 1971). Similarly, the in vitro generation of cytotoxic effector cells to 
alloantigens in MLC systems [cell-mediated lympholysis (CML)] has been shown to 
require macrophages in mice (Wagner et al., 1972). However, whether macrophages 
function to enhance the immunogenicity of alloantigens is unclear. An alternative 
explanation for the requirement for macrophages in MLC is that the primary stimu- 
lating cell in the MLC is the allogeneic macrophage. This has been observed with 
MLC in guinea pigs (Greineder and Rosenthal, 1975b), humans (Rode and Gordon, 
1974) and rats (Oehler and Herberman, 1977). In these studies, syngeneic macrophages 
did not reconstitute the MLC responses abrogated by depletion of macrophanges from 
both stimulating and responding populations. 
T cell proliferative responses to nonspecific mitogens have also been shown to 
require macrophages. Rosenstreich and Oppenheim (1976) have recently reviewed 
evidence that T cell proliferative responses to Concanavalin A (Con A) and phyto- 
hemagglutinin (PHA) in guinea pigs are macrophage dependent. Nonadherent human 
peripheral blood mononuclear leukocytes (PBL), purified by passage over a column 
containing glass beads, have a diminished proliferative response to PHA which could 
be reconstituted with as few as 1 per cent phagocytic cells (Oppenheim et al., 1968). 
Both Oppenheim et al. (1968) and Lohrmann et al. (1974) have shown that the 
dependence of human lymphocytes on monocytes for strong proliferative responses 
to PHA is much easier to demonstrate when suboptimal concentrations of PHA are 
used. Our laboratory has recently separated human PBL on the basis of adherence by 
passage of the cells through Sephadex G-10 columns (Jerrells, Dean and Herberman, 
unpublished observations) and determined the reactivity to PHA and Con A. We 
found that populations depleted of adherent cells, with less than 1 per cent esterase 
positive cells, were essentially unresponsive to Con A, whereas the responses to PHA 
were diminished less consistently, if at all. Reconstitution of the nonadherent ceils 
with irradiated adherent autologous Cells which were enriched for esterase positive 
cells (monocytes) resulted in enhanced PHA and Con A responses, equal to or even 
greater than the response of ,~e original untreated population. Similarly, in other 
experiments, we have observed that human PBL forming rosettes with SRBC (E- 
RFC), when separated from non-rosetting cells by centrifugation in a FicolI-Hypaque 
density gradient, may proliferate little if at all in response to Con A (Dean et al., 1977; 
West, Dean and Herberman, unpublished observations). As observed with the adher- 
ent cell-depleted populations described above, the PHA response was diminished less 
than the Con A response. Approximately 1 per cent of the cells prepared in this way 
stained positive for esterase or ingested latex particles, and essentially none of the 
cells had detectable surface IgM. When such populations were further depleted of 
cells bearing an Fc receptor by adherence to monolayers of antibody-coated SRBC 
attached to Petri dishes with poly-I-lysine (West et al., 1977), the nonadherent 
population (consisting of cells lacking the Fc receptor and esterase) also failed to 
respond to PHA. When reconstituted with various concentrations of adherent 
autologous PBL, the response to both mitogens was restored. These observations 
suggest that human PBL require adherent cells, presumably macrophages, to proli- 
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ferate in response to Con A and that fewer such cells, or a particular subpopulation of 
adherent cells bearing an Fc receptor, are needed for responses to PHA. Blaese et al. 
(1977), in studies with human PBL, have provided evidence that different macro- 
phage-dependent in vitro responses may have varying requirements for macrophages. 
By using a series of macrophage depletion techniques, they could show a hierarchy of 
macrophage dependence for several in vitro responses. Monocyte-mediated antibody- 
dependent cell-mediated cytotoxicity (MMADCC) was the assay system most depen- 
dent on macrophages. Since macrophages are the effector cells in this assay, even 
minimal decreases in the percentage of macrophages were associated with decreased 
cytotoxicity. As more efficient macrophage depletion techniques were used, the 
synthesis of immunoglobulin induced by pokeweed mitogen (PWM) was depressed. 
Only the most efficient means of macrophage depletion caused depression of the 
proliferative response to soluble antigens (Candida and SK-SD). Although less 
dependent on macrophages than MMADCC and the PWM response, the proliferative 
response to soluble antigens was still shown to be macrophage-dependent. In contrast 
to our findings, these investigators could not demonstrate a macrophage requirement 
for a proliferative response to PHA even by using a Shortman column (Shortman, 
1968), their most effective technique, to deplete the adherent ceils. All of these data 
indicate tha t the  proliferative response of human PBL to optimal concentrations of 
PHA requires very few macrophages indeed. 
T cell proliferation in response to the immunological adjuvant Bacillus Calmette- 
Gu6rin (BCG) in vitro requires the presence of macrophages (Mokyr and Mitchell, 
1975). Mouse thymus cell suspensions, which contain approximately 0.25 per cent 
macrophages, responded vigorously to BCG, incorporating 3H-thymidine 25-35-fold 
more than unstimulated controls. When macrophages were depleted to <0.25 per 
cent (undetectable by Giemsa stain), .the response to BCG was abolished. There was 
no diminution of the response to Con A, indicating viability of the nonadherent 
thymus cells, and reconstitution of macrophages to 0.5 per cent completely restored 
the response to BCG. Reduction of macrophages in the spleen from 10 to 0.5 per cent 
caused no change in two experiments, but significant augmentation of 3H-thymidine 
incorporation in response to BCG in two others (Mokyr and Mitchell, 1975). Thus, a 
critical concentration of macrophages 0.25-0.5 per cent was required for the mitogenic 
effects of BCG on T cells, with higher concentrations tending to cause diminished 
reactivity of lymphocytes. 
T cell proliferative responses induced by sodium periodate or neuraminidase- 
galactose oxidase (NG) require macrophages in guinea pigs (Greineder and Rosenthal, 
1975a). In this system, treatment of either macrophages or T cells alone with these 
materials resulted in strong proliferative responses when the cells were recombined. 
In contrast, purified lymphocytes treated with periodate or NG and also pretreated 
with mitomycin C to prevent their own proliferation could not induce a T cell 
proliferative response when added to unfractionated guinea pig lymph node cells. 
These observations further confirm the requirement for interaction between T cells 
and macrophages in the generation of proliferative responses to nonspecific stimuli. 
Proliferative responses of primed T cells to soluble protein antigens have been 
shown to require macrophages in several systems. In guinea pigs immunized with 
ovalbumin (OVA) in complete Freund's adjuvant (CFA), lymph node cells depleted of 
adherent cells did not proliferate in response to the antigens unless reconstituted with 
adherent cells (Seeger and Oppenheim, 1970; Walderon et al., 1973; Rosenthal and 
Shevach, 1973; Paul et al., 1976). In addition, purified macrophages, but not lym- 
phocytes preincubated with purified protein derivative of tuberculin (PPD) or OVA 
and added to purified lymph node cells from immunized animals, induced strong 
proliferative responses in vitro (Rosenthal and Shevach, 1973; Paul et al., 1976). 
Similarly, Cline and Swett (1968) have shown that when human PBL from tuberculin- 
sensitive donors were depleted of adherent cells, no blastogenic response was 
observed in the presence of PPD. Addition of adherent cells with the characteristics 
of monocytes to the cultures of purified PBL and PPD resulted in strong proliferative 
560 J. RONALD OEHLER et al. 
responses. Viable monocytes were required and separation of the responding lym- 
phocytes from the monocytes with cell-impermeable Millipore membranes prevented 
the enhancing effect. Similar findings using human PBL have been reported by Blaese 
et al. (1972). 
Primary T cell proliferative responses to soluble protein antigen in vitro have been 
difficult to demonstrate. However, recently antigen-pulsed macrophages were used to 
prime purified guinea pig LNC in vitro for subsequent proliferative responses upon 
re-exposure to antigen-pulsed macrophages (Thomas and Shevach, 1976). As will be 
discussed, these types of experiments have allowed a more detailed understanding of 
the macrophage-lymphocyte interaction than was previously possible in experiments 
where T cells were primed in vivo. 
2.2.2.1. The requirement for  macrophages for  the production of  lymphokines in 
vitro. In addition to the induction of T cell division, antigens and mitogens induce the 
production by T cells of numerous mediators termed lymphokines. In vitro systems 
have been developed to investigate the events leading to lymphokine production. Thus 
far, all such in vitro systems show that macrophages are required for the production 
of mediators by T cells. 
Migration inhibition factor (MIF) production by guinea pig lymphocytes primed 
with CFA required macrophages pulsed with PPD (Ohishi and Onoue, 1975). In this 
case, the macrophage requirement could be replaced by supernatants of macrophages 
stimulated with lipopolysaccharide (LPS) (Ohishi and Onoue, 1976). Similarly, our 
laboratory (Landolfo et al., 1978) has recently shown that spleen 
cells from C57BL/6 mice bearing Moloney sarcoma virus-induced tumors could 
be induced to produce MIF by culture with 3 M KC! extracts of tumor cells 
bearing relevant antigens. Spleen cells depleted of macrophages by adherence 
techniques did not produce MIF when cultured with the 3 M KC1 extract. However, 
when purified macrophages from light mineral oil-induced peritoneal exudates of 
normal syngeneic mice were added to the adherent cell-depleted spleen cells in the 
presence of free antigen, MIF production could again be demonstrated. Further, 
spleen cells with macrophages which were preincubated with soluble tumor antigens 
for 2-6 hr and washed to remove all unbound antigen could also produce MIF. More 
recently, we have shown that only antigen-pulsed spleen cells containing macrophages 
compatible with the responding cells at the major histocompatibility complex (MHC) 
could produce MIF (Landolfo et al., 1977). Unlike the findings of Ohishi and Onoue 
described above for the PPD system in guinea pigs, the macrophage requirement in 
the MSV tumor system has been shown to require cell-cell contact and could not be 
replaced by supernatants of LPS-stimulated macrophages (Landolfo, Holden and 
Herberman, unpublished observations). 
In addition to MIF, a number of other mediators are produced by stimulated T cells 
in vitro. Macrophages were required for interferon production by PBL from tuber- 
culin-sensitive human donors in response to PPD in vitro (Epstein et al., 1971a). 
Unprimed human lymphocytes stimulated with PHA produced interferon only in the 
presence of macrophages (Epstein et al., 1971b). Osteoclast-activating factor (OAF) 
produced by human PBL in response to PHA required adherent cells (Horton et al., 
1974). In guinea pigs, T cell production of macrophage chemotactic factor by primed 
T cells stimulated with soluble antigen required macrophages (Wahl et al., 1975). In 
sensitized humans, the production of fibroblast chemotactic factor in vitro by PBL 
stimulated with the sensitizing antigen required the presence of adherent cells 
(Postlethwaite et al., 1976). 
In summary, all immune responses involving triggering of T cells, whether to help B 
cells respond to T-dependent antigens, to help other T cells to become effector cells, 
or to mediate effector functions themselves, require at least small numbers of 
macrophages. In our discussion we have made no effort thus far to distinguish 
between those macrophage requirements dependent on cellular contact with T cells 
and the ability of macrophage products to effectively replace the actual adherent cell. 
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Similarly, for most of the systems discussed, we have made no distinction between 
those T cell responses shown to require macrophages which share some region in the 
MHC and those in which no genetic restriction has been described. Oppenheim and 
Rosenstreich (1976) have recently reviewed these issues and have presented evidence 
suggesting that T cell responses to nonspecific mitogens and cellular antigens, i.e., to 
alloantigens in MLC or CML or heterologous erythrocyte antigens such as SRBC, 
do not require the presence of intact and viable macrophages in the culture, but 
instead only require soluble factors from macrophages such as lymphocyte-activating 
factor (LAF) (Gery et al., 1972). These factors act, with the cellular antigens or 
mitogens, as 'second signals' analogous to second signals required for B cell activation 
to promote T cell triggering and to amplify the response (Rosenstreich and Oppen- 
heim, 1976). Several lines of evidence account for these views. Antibody production 
to heterologous erythrocytes in vitro required T cells and macrophages as well as B 
cells as previously described. However, Calkins and Golub (1972) have shown that 
macrophages could provide the helper effect even when separated from macrophage- 
depleted spleen cells by a cell-impermeable Millipore filter. The antigen (SRBC in this 
case) and not the macrophages had to be in contact with the responding cells. Further, 
Chen and Hirsch (1972; and reviewed by Chen and Hirch, 1975) have shown that 
the requirement for macrophages in a Mishell-Dutton culture system could be 
replaced entirely with various thiols, of which the most widely used is 2-mercap- 
toethanol (2-ME). Addition of such agents to lymphoid cells in tissue culture has long 
been known to enhance the viability of the cells remaining after several days in 
culture (Fanger et al., 1970; Click et al., 1972). When even small numbers of 
macrophages were added to nonadherent mouse spleen cells in the absence of 2-ME, 
the viability was shown to be similarly increased (Pierce and Kapp, 1976). However, 
Pierce and Kapp (1976) have suggested that rather than replacing macrophages in 
Mishell-Dutton cultures, 2-ME simply augments the activity of the small number of 
macrophages left in culture after macrophage depletion procedures. This, of course, 
may be difficult to directly demonstrate until cell populations can be depleted of 
macrophages so efficiently that they will not respond to cellular antigens under 
optimal conditions even in the presence of 2-ME. 
T cell responses to cellular alloantigens in MLC and CML have also been shown to 
be supported by factors from cultures of macrophages (Bach et al., 1970) and by 
2-ME in mice (Bevan et al., 1974). As discussed earlier, in guinea pigs, rats and 
humans, macrophages must be present only in the stimulating cell population as the 
primary stimulating cells. In this respect, they play a dual role of both presenting the 
alloantigens to the responding T cells as well as nonspecifically supporting the 
response (Rosenstreich and Oppenheim, 1976). In addition to T cell responses to 
alloantigens, T cell proliferative responses to nonspecific mitogens can also be 
supported by macrophage factors. In the presence of macrophage products, even 
purified T cells respond well to PHA (Rosenstreich and Oppenheim, 1976). Similarly, 
the Con A response of T cells requires only macrophage factors. In the situation 
where macrophage products or thiols such as 2-ME can replace the requirement for 
macrophages, there is obviously no necessity that the macrophages producing the 
factors share MHC components with the responding T cells. 
In contrast to the T cell responses to cellular antigens and mitogens just discussed, 
T cell responses to soluble protein antigens have been shown to require the actual 
presence of viable macrophages in the culture system (for review, see Rosenstreich 
and Oppenheim, 1976). For these cellular interactions, the MHC does appear to play 
an important role. This will be discussed in detail in the section on antigen presen- 
tation (Section 2.3.2). 
2.3. MECHANISMS OF ACTION 
The immunogenicity of many soluble protein antigens appears to be correlated with 
the ability of in s i tu  macrophages to take up and process the antigen (discussed above 
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in Section 2.1). Antigens not taken up well in vivo, and therefore poorly immunogenic, 
could be preincubated with macrophages and injected as macrophage-bound antigen. 
Antigens treated in this way were highly immunogenic and never produced tolerance. 
B cell tolerance to T-dependent antigens (all soluble protein antigens are T-dependent) 
has been associated with the prolonged exposure of the B cells to free antigen in the 
absence of activated helper T cells (for review, see Klaus et al., 1976). One com- 
ponent of the mechanism of increased immunogenicity associated with macrophage- 
bound antigen may be that antigens administered in this way are less likely to be 
exposed to B cells in free form than are antigens injected without macrophages. All T 
cell responses to soluble protein antigens, either production of mediators or proli- 
ferative responses, require viable macrophages. In addition to preventing prolonged 
exposure of B cells to antigens, the evidence suggests that macrophages are also 
needed to present soluble protein antigens to T cells. With these points in mind, we 
can first discuss antigen processing by macrophages and then the ability of macro- 
phages to present antigens to T cells. 
2.3.1. Antigen Processing 
Most antigen picked up by macrophages in vitro is endocytosed and broken down 
into nonimmunogenic fragments (Unanue, 1972; Ellner and Rosenthal, 1975). A small 
percentage of the antigen associated with the macrophage remains on the cell surface 
and is highly immunogenic (Unanue, 1972). In mice, the antigen on the surface of 
macrophages is trypsin-sensitive and can be detected by specific antibody (Unanue et 
al., 1969b). Further, when mouse macrophages were preincubated with soluble protein 
antigens and then exposed to antigen-specific antibody or were trypsinized prior to in 
vivo inoculation, the resulting antibody response was largely abrogated (Unanue, 
1972). In guinea pigs tile observations are more complex. Walderon et al. (1974) have 
provided evidence that guinea pig macrophages pulsed with PPD at 4 ° and then 
trypsinized while at 4 ° were no longer immunogenic. In contrast, when guinea pig 
macrophages were pulsed with PPD at 37 °, only a fraction of the immunogenicity was 
trypsin sensitive. Further, when macrophages were pulsed at 4 ° and then incubated at 
37 ° before trypsinization, the macrophage-associated immunogenicity became pro- 
gressively more trypsin resistant. This led these investigators to postulate two steps in 
antigen processing by macrophages. The first consisted of antigen binding to the 
macrophage surface, which was trypsin-sensitive and temperature-independent. The 
second step involved either internalization or sequestration of the immunogenic 
component in the folds of the membrane rendering it relatively insensitive to tryp- 
sinization. Similarly, Ellner and Rosenthal (1975) have shown that antigen taken up by 
guinea pig macrophages was resistant to trypsin and could not be detected by specific 
antibody. They have postulated that the macrophage-lymphocyte interaction might 
induce a return of the antigen to the surface of the macrophage where it would be 
available for presentation to T cells. Calderon and Unanue (1974) studied the handling 
of KLH by macrophages and found that a small percentage (3-7 per cent) of the 
antigen picked up by macrophages in vitro was internalized and slowly released into 
the medium as a smaller molecule than the original antigen, and that part of this 
fragment was still reactive with anti-KLH antisera. This protein release was asso- 
ciated with live macrophages and was trypsin-resistant. In addition, its release was 
independent of protein synthesis. 
In summary, there is general agreement that the majority of the antigen phagocy- 
tized by macrophages is degraded into nonimmunogenic fragments and released. This 
may play an important role in preventing tolerance induction. In addition, a small 
percentage of the antigen is maintained on the surface of the macrophages where it is 
highly immunogenic. In mice, the antigen is trypsin-sensitive and detectable by 
specific antibody. In guinea pigs, the immunogenic fragments are trypsin-resistant and 
cannot be detected by specific antibody, suggesting they may be sequestered in the 
membrane. Finally, some of the immunogenic portions of the molecule may be 
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internalized, to be slowly released in an immunogenic form for a variable length of 
time. The biochemical events involved in these processes are largely unknown. 
2.3.2. Antigen Presentation 
2.3.2.1. Antigen presentation by macrophages: effects on T cells. Whereas antigen 
processing concerns the effects of macrophages on antigens which result in altered 
and frequently enhanced immunogenicity as compared to the native form, antigen 
presentation is concerned with the macrophage-lymphocyte interaction which results 
in antigen-specific triggering of lymphocyte responses. The most recent concepts of 
antigen presentation by macrophages grew largely out of studies of the genetic control 
of the immune response. Certain strains of mice (Benacerraf and McDevitt, 1972), 
guinea pigs (Paul and Benacerraf, 1974) and rats (Kunz and Gill, 1974) have been 
found to be high or low antibody responders to specific antigens. The ability to mount 
a strong antibody response to many antigens was linked to the MHC (Benacerraf and 
McDevitt, 1972; Kunz and Gill, 1974). By use of recombinant strains of mice for 
genetic mapping, the immune response (Ir) genes have largely been found to be 
located in the I region of the MHC although in some cases the H-2K region has not 
yet been ruled out (Shreffler and David, 1975). Ir gene expression, or the ability to 
generate immune responses to antigens under Ir gene control, was once thought to be 
primarily a property of T cells (Paul and Benacerraf, 1974). Now, however, macro- 
phages in the guinea pig (Shevach, 1976) and the rat (Tada et al., 1976) and probably 
B cells, in some cases in mice (Mozes and Shearer, 1971), are thought to express Ir 
genes. The I region of the MHC also codes for I region-associated (Ia) cell surface 
antigens found on the membranes of subpopulations of T cells, B cells and macro- 
phages as well as some nonlymphoid ceils (Hammerling, 1976). That Ia antigens are 
important in macrophage-T cell interactions is indicated by the fact that antisera 
directed toward these Ia antigens have been shown to block T cell proliferative 
responses to macrophage-bound soluble antigen (Shevach and Rosenthal, 1973; She- 
vach, 1976). Further, recent evidence has been presented that antisera directed toward 
Ia antigens coded for in the I-J subregion of the MHC (recently described by Murphy 
et al., 1976), when preincubated with macrophages but not the macrophage-depleted 
responding lymphocytes, could block the in vitro humorai response to burro red blood 
cells (BRBC) (Neiderhuber and Shreffler, 1976). Studies of lymphoid cellular inter- 
actions have suggested that T celI-B cell collaboration in vitro and in vivo required 
identity at various I subregions of the MHC (Katz et al., 1973a, 1976). Similar 
requirements have been suggested for the ability of macrophages to present antigens 
to T ceils for helper cell induction (Erb and Feldmann, 1975b, 1976) and for induction 
of antigen-specific T cell proliferative responses (Rosenthal and Shevach, 1973). 
However, exceptions to this rule have been reported. Pierce et al. (1976) and Kapp et 
al. (1973) have shown that completely allogeneic macrophages can prime T cells in 
vitro to become helper cells for antibody-forming cell (AFC)'production to GAT (a 
random terpolymer of L-glutamic acid-L-alanine-L-tryosine). In addition, Heber- 
Katz and Wilson (1976) have shown rat T cells, 'filtered' through irradiated F~ hybrid 
rats to deplete alloreactive cells, could collaborate with allogeneic B cells in a primary 
in vitro anti-SRBC response. These experiments, then, suggest that Ia compatibility 
may not be required for cellular interactions of unprimed cells. 
Similar experiments have been performed in vivo. Bechtol et al. (1974) have used 
tetraparental (allophenic) chimeric mice constructed from the fusion of mouse 
embryos of strains which are high (CWB) and low (C3H) responders to Poly L-(Tyr, 
Glu)-poly-D, L-Ala-poly-L-Lys (TGAL). These strains are congenic on the C3H 
background, differing for the Ig allotype and the H-2 complex. The percentage of 
each parental lymphoid cell type in the adult chimeric mice could be determined by 
allotype analysis of the serum immunoglobulin. Those mice with a high percentage of 
the CWB Ig allotype proved to be high responders to TGAL and those with a low 
percentage of the CWB allotype were poor responders. This suggested that the 
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genetic responsiveness was still associated with the predominant lymphoid cell type in 
the chimeric mice. However, when high responder chimeric mice were immunized 
with TGAL, the anti-TGAL response consisted of antibody of both allotypes and the 
ratio of the CWB allotype to the C3H allotype had not changed from the resting state. 
This suggested that B cells of both haplotypes responded to CWB T cell help, thus 
providing evidence that T-B collaboration could occur in v ivo  despite MHC 
differences. These observations were further supported by the experiments of von 
Boehmer et al. (1975a). They adoptively transferred, into lethally irradiated Fj mice, 
SRBC primed T cells from tetraparental bone marrow chimera mice which were 
depleted of cells from the other parental donor by treatment with alloantisera and 
complement. The recipients were then inoculated with SRBC and with SRBC-primed 
B cells depleted of T cells by anit-theta plus complement from the opposite parental 
strain. These allogeneic, primed T and B cells cooperated well to give a strong 
anti-SRBC response. Since these investigators (von Boehmer et al., 1975b) had 
previously demonstrated the lack of alloreactivity between T cells from chimeric mice 
and cells from mice of one of the parental strains, the observed response was not due 
to an allogeneic effect. Similarly, Bechtol et al. (1976) have provided convincing 
evidence that the anti-TGAL responses (discussed above) in C3H~-~CWB tetra- 
parental mice were in no way due to an allogeneic effect. These experiments have 
clearly shown that, at least in some situations, T cells and B cells can collaborate in 
v ivo  despite I region differences. To provide an explanation for these observations, 
Pierce et al. (1976) have recently pointed out that the Ia identity requirement had been 
seen in experiments using primed cells in secondary responses, whereas those 
investigators not observing the Ia identity genetic restriction had tested either primary 
responses or responses of T cells primed in a chimeric environment (Kapp et al.,  1973; 
Pierce et al., 1976; Heber-Katz and Wilson, 1975). Further,. Pierce et al. (1976) 
demonstrated that T cells primed in v ivo  with allogeneic macrophages required 
macrophages syngeneic to those used for priming, to trigger a secondary response. 
Moreover, macrophages syngeneic to T cells primed with allogeneic macrophages 
could not be substituted for allogeneic macrophages for the secondary challenge. 
These findings are supported by the work of Miller et al. (1976a), using an adoptive 
transfer of delayed hypersensitivity (DTH) system in mice. They have shown that T 
cells of one parental haplotype, sensitized in a chimeric environment, could adop- 
tively transfer DTH to either of the parents despite total histoincompatibility. Further, 
T cells from (BALBlc × CBA)Fj hybrid mice, sensitized in either BALB/c or CBA 
nude mice, could transfer DTH reactivity only to the parent syngeneic to the nude 
mouse in which they were sensitized (Miller et al.,  1976a). They previously showed 
that F~ cells sensitized in an F~ environment could transfer DTH reactivity equally well 
to either parent (Miller et al.,  1976b). These experiments support the notion that the 
original macrophage-T cell interaction is responsible for genetic restrictions observed 
for macrophage interactions with primed T cells. More direct evidence for this 
hypothesis has been provided by recent reports of Thomas and Shevach (1976, 
1977a, b). They showed that purified lymph node cells of (strain 2x strain 13)F~ 
guinea pigs, primed in v i tro  with OVA-pulsed macrophages from either 
parent, could be restimulated only with macrophages of the same parent pulsed 
with the same antigen. In contrast, F~ LNC primed with F1 macrophages would 
respond to either of the parental macrophages in a secondary response (Thomas and 
Shevach, 1976). These experiments, however, only showed priming of Fj LNC by 
macrophages, albeit with interesting genetic restrictions for subsequent T cell re- 
stimulation. To examine priming of T cells with totally allogeneic macrophages, they 
had to pretreat the macrophages with specific anti-Ia antisera to block alloantigen 
sensitization which would otherwise result in a strong secondary MLC upon re- 
exposure of the allogeneic macrophages to the allosensitized T cells. They found that 
the antisera, in addition to blocking the Ia determinant on the macrophages, served as 
an antigen to which the T cells could be sensitized. Once primed, the T cells 
responded secondarily only to macrophages of the same haplotype which were treated 
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with anti-Ia antisera. Neither macrophages of the proper haplotype without pretreat- 
ment with anti-h, nor syngeneic macrophages regardless of treatment with anti-Ia 
stimulated. Therefore, this represents a clear example of T cell priming with histoin- 
compatible macrophages, the secondary response of which was specific not only for 
the antigen but also for the haplotype of the macrophage used for the initial priming. 
Further, these investigators found that antisera toward the B.1 MHC determinant 
(analogous to the H-2 K and D regions in the mouse) also could act as an antigen and 
that the Ia genetic restriction for secondary stimulation was operative in this case 
also. On the basis of these data, they have suggested that protein antigens bound to Ia 
and other MHC molecules on macrophages serve as 'complex antigenic determinants' 
to which T cells are primed. Moreover, they concluded that Ia antigens must 
indirectly influence the presentation of antigen bound to other MHC molecules since 
only anti-B.1 treated macrophages with Ia determinants identical to those of the 
anti-B.1 treated macrophage used for priming could elicit a secondary proliferative 
response (Thomas and Shevach, 1977a). In addition, they have shown that TNP- 
modified macrophages could specifically sensitize allogeneic T cells, but only after the 
alloreactive clone of T cells was depleted by treatment with BUdR and light during a 
primary MLC. The reason for this was not obvious, but since not even syngeneic 
macrophages, modified with TNP, could sensitize T cells during a MLC proliferative 
response, it was likely that a suppressor mechanism was being generated which was 
dependent on the proliferation of the alloreactive cells (Thomas and Shevach, 1977b). 
Paul et al. (1976) have recently shown that guinea pig LNC primed in vivo with 
OVA could be restimulated in vitro with antigen-pulsed macrophages from either 
parent, and if during the proliferative phase of the secondary response induced by 
such antigen-pulsed macrophages, the responding cells were treated with BUdR and 
exposed to light, thus eliminating the proliferating clone, the remaining cells could be 
stimulated only with OVA-pulsed macrophages from the alternate parent. Positive 
selection experiments showed that if F~ LNC, primed in vivo, were restimulated with 
OVA-pulsed macrophages of one parent, the responding cells were then hyper- 
responsive for OVA-pulsed macrophages of that parent but only modestly responsive 
to OVA-pulsed macrophages of the other parent. 
All of these data can be explained by the hypothesis that the original macrophage-T 
cell MHC relationship established a preference in the secondary response for macro- 
phage MHC antigen which induced the primary response. I, D and K region identity 
primary sensitization, T cells appear to recognize antigens in complex or association 
with MHC antigens on macrophages. For secondary stimulation then, the primed T 
cell requires presentation of antigen in complex or association with the same macro- 
phage MHC antigen which induced the primary response. I, D, and K region identity 
requirements for secondary T cell stimulation have been demonstrated depending on 
the antigen used (Miller et al., 1976a; Paul et al., 1976; Thomas and Shevach, 1976; 
Pierce et al., 1976). In the case of F~ cells sensitized in an Fj environment, or parental 
cells sensitized in a chimeric environment, two clones of antigen-reactive cells may be 
generated, one for each macrophage haplotype expressed during the sensitization. 
In summary, these recent observations indicate that MHC gene products on 
macrophages play a critical role in the sensitization process of the T cell and that T 
cell receptors recognize antigen in complex or association with macrophage Ia or 
other MHC determinants. Paul et al. (1976) have postulated that the MHC has evolved 
as the basis for cellular interactions which are essential for the competence of the 
immune response. This interesting hypothesis serves to point out the rather central 
role of macrophages in induction of T cell-dependent immune responses. 
2.3.2.2. Ant igen  presentat ion  by macrophages :  effects on B cells. In contrast to the 
recent advances in understanding of the macrophage-T cell interaction, the macro- 
phage-B cell interaction has received little attention. Rather, the T cell-B cell 
interaction has been stressed (Katz et al., 1973a, b, 1976; reviewed in Katz and 
Benacerraf, 1972). The demonstration that T-independent B cell antigens were also 
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macrophage independent (Shortman et al., 1970; Mosier et al., 1974; Feldmann, 1972a, 
b) has suggested that the primary or sole role of macrophages is to sensitize T cells 
and only through that mechanism could macrophages influence B cell responses. 
However, recent demonstrations that B cell responses to some T-independent 
antigens either require or are greatly enhanced by macrophages (Chused et al., 1976; 
Lee et al., 1976; Pike and Nossal, 1976) suggest that macrophages may play a role in B 
cell activation and that their effect on B cells in these responses may have been 
overlooked. There is, in fact, some evidence that activated macrophages produce 
factors that can stimulate B cells directly to respond to T-dependent antigens in the 
absence of T cells (Schrader, 1973; Wood and Gaul, 1974; Hoffman et al., 1976a, b; 
Wood and Cameron, 1975). In addition, there is evidence that T cell helper factors 
may require macrophages to activate (or provide a second signal for) B cells. 
Feldmann (1972c) has reported experiments done in double chambered Marbrook 
vessels in which primed T cells, separated from T cell-depleted spleen cells by a 0.1 
Nucleopore membrane, could induce specific AFC production by the T cell-depleted 
spleen cells in the presence of the priming antigen (DNP-KLH).  When macrophages 
were also depleted from the T cell-depleted spleen cells, no specific AFC production 
could be demonstrated. Reconstitution of the spleen cells with purified anti-theta and 
complement-treated PEC (macrophages) again resulted in specific AFC production. 
Further, when primed T cells were cultured in the upper chamber of the Marbrook 
vessel with DNP-KLH,  and purified PEC were cultured alone in the lower chamber, 
Feldmann (1972c) found that the thoroughly washed PEC could induce a strong 
antigen-specific AFC response when combined with T cell-depleted spleen cells in a 
secondary culture devoid of additional antigen. From such experiments, Feldmann 
(1972c) concluded that macrophages were required to present the antigen-T cell factor 
complex to B cells. Schrader and Feldmann (1973) arrived at similar conclusions 
during investigations of antigenic competition. In these experiments, mice which had 
been primed with fowl gamma globulin (FGG) were injected with donkey RBC 
(DRBC) i.p. or i.v. 2 days before serving as donors of spleen cells to be used in a 
Marbrook-Diener culture system to produce AFC to DNP coupled to FGG. They 
found that the AFC response was very poor when DNP-FGG was used as an antigen, 
but when DNP was coupled to a thymus-independent antigen such as flagella (FLA), a 
strong AFC response was observed. This indicated that the B cells were fully 
competent to produce antibody when triggered by a T-independent antigen and 
suggested the defect in the response to DNP-FGG was in either the T cells or the 
macrophages. They found that addition of very small numbers of normal macrophages 
to the system (0.2 per cent of the responding cells) allowed a normal AFC response, 
compared to the response of cells from FGG-primed mice not preinjected with 
DRBC. In addition, the ability to respond to DNP-FGG was restored by trypsinizing 
the responding cells prior to culture. From these experiments, they concluded that 
macrophages in the spleens of mice pre-injected with DRBC were unable to present 
the T cell helper factor to the B ceils due to the pre-injection with DRBC in v ivo.  The 
trypsinization, they concluded, acted to remove a surface inhibitor from the surface 
of the macrophages. 
Further evidence that macrophages alone can enhance B cell antibody production 
was provided by Opitz et al. (1976). They showed that normal mouse spleen cells 
would generate a polyclonal antibody response in a Mishell-Dutton culture system if 
cocultivated with high concentrations of mouse PEC for 8 hr before depleting the 
spleen cells of all phagocytic cells and reculturing them in media containing 2-ME. 
Control cultures not cultured with high numbers of mouse PEC generated no such 
response. 
In summary then, these observations suggest that macrophages can have significant 
effects on B cell responses to both T-dependent and T-independent antigens. In view 
of the recent work describing the mechanisms of antigen presentation to T cells by 
macrophages (previous section), it seems likely that macrophages may also be 
involved in the presentation of T cell-dependent helper factors to B cells. Alter- 
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natively, primed T cells, upon activation by antigen, may liberate factors which 
activate macrophages which then provide a second signal to B cells for specific AFC 
production. Considering the changing concepts of the genetic restrictions (or lack 
thereof) on T cell-B cell collaboration and macrophage-T cell interactions, it would 
seem that further investigations are needed on the role of macrophages in the 
relationship between T cells and B cells as well as their role in stimulating B cells 
directly. 
3. SUPPRESSION OF IMMUNE RESPONSES BY MACROPHAGES 
In the previous sections we have discussed evidence that macrophages can enhance 
immune responses in vivo and in vitro. Various mechanisms were discussed, both in 
terms of the effect of macrophages on the antigen itself and the requirement for 
macrophages of various lymphocyte responses to antigens and mitogens. In most 
cases, normal macrophages in very low concentrations were used to demonstrate 
these enhancing effects. 
In this section, we shall concenh-ate on suppressive effects of macrophages on the 
immune response. In contrast to the enhancing effects, the suppressive effects have 
usually been seen with greater concentrations of macrophages or with highly activated 
macrophages. First, we shall describe a series of basic observations made in our 
laboratory and in others which provide a framework on which a more general concept 
of immunosuppression resulting from the inhibition of lymphocyte proliferation by 
cells of the reticuloendothelial system (RES) can be constructed. What is known 
about the mechanism of macrophage-mediated cytostatic effects will be reviewed. We 
suggest that 'activation' of macrophages is a relative term and that the degree of 
suppression is related not only to the activation state of the macrophages but also to 
the number of macrophages in the proximity of an expanding clone of lymphocytes. 
We shall discuss various ways in which macrophages can become activated and 
thereby become more suppressive. An important recent finding which will be 
emphasized is that T cells can generate suppressor macrophages via a factor isolated 
from Con A-induced suppressor T cells. Therefore, suppressor T cells may exert their 
effects indirectly through activation of suppressor macrophages. 
We shall then discuss the evidence that suppressor macrophages in vitro and an 
activated reticuloendothelial system (RES) in vivo can be shown to have similar 
effects on lymphocyte responsiveness. A number of examples of suppressed immune 
responses associated with an activated RES will be discussed, along with evidence 
that in many cases the cell which mediates the suppressor effect is probably an 
activated macrophage. Finally, we shall discuss the observations that macrophages, 
usually considered to be nonspecific in their effects, may in fact be able to distinguish 
between neoplastic and non-neoplastic cells. 
3.1. BASIC OBSERVATIONS 
Our laboratory has recently investigated a number of cases of suppressed immune 
responses in vitro and, in many instances, has identified the responsible agent as a 
macrophage (Kirchner et al., 1974a, b, c, 1975a, b; Oehler et al., 1977a, b; Fernbach 
et al., 1976a, b; Glaser et al., 1976; reviewed in Kirchner et al., 1976). Many of the 
original observations were made by Kirchner et al. (1974a, b, 1975a). It was initially 
observed that spleen cells from C57BL/6 mice bearing tumors induced by inoculation 
with Moloney sarcoma virus (MSV) responded poorly if at all to T cell mitogens such 
as PHA and Con A and frequently had a depressed response to the B cell mitogen 
LPS (Kirchner et al., 1974a, b). There were several possible explanations for such 
findings. If T cells, and occasionally B cells, migrated from the spleen during the 
growth of the tumor, the lack of cells even potentially capable of responding to 
mitogens when cultured in vitro could account for the defect. However, purification 
of the lymphocytes by passing the spleen cells from MSV tumor-bearing mice (MSV 
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spleen cells) over a rayon adherence column [a technique by which cells capable of 
ingesting latex particles were largely depleted but the ratio or surface immunoglobulin 
(Ig) positive to Ig negative cells was essentially unchanged (Kirchner et al., 1974a)] 
reconstituted the proliferative response to the mitogens (Kirchner et al.,  1974a, b). 
Therefore, cells capable of responding to the mitogens were present in the spleen. 
Thus two possible explanations remained: either the potentially responsive cells were 
diluted by an influx of ceils which would not respond to mitogens (Smith and Konda, 
1973), or a population of adherent cells was present which somehow prevented the 
potentially responsive cells from proliferating. To test whether a suppressive effect 
was playing a role in the failure of the MSV spleens to respond to mitogens, spleen 
cells from MSV tumor-bearing mice were mixed with spleen cells from normal mice 
and the mixture was incubated with PHA. Virtually no proliferative response was 
observed in the cell mixture, demonstrating the role of suppressor cells (Kirchner et 
aL, 1974b). To characterize the cell or cells responsible for the suppressive effect, a 
number of subpopulations of cells from MSV spleens were tested for their sup- 
pressive effects on the proliferative response of normal spleen cells to PHA. 
Pretreatment of the MSV spleen cells with anti-theta and complement to remove T 
cells had no effect or actually increased the suppressive effects (Kirchner et al., 1974b. 
1975a). In contrast, depletion of adherent cells by passage over a rayon column, or of 
phagocytic cells by pretreatment with iron powder and magnet, totally abrogated the 
suppressive effect (Kirchner et al.,  1974b). In addition, pretreatment of the cells with 
carrageenan, which is specifically toxic for macrophages and not for lymphocytes 
(Lake et al., 1971), largely abrogated the suppression (Kirchner et al., 1975a). Further, 
the suppressor activity was resistant to 2500r X-irradiation (Kirchner et al., 1975a). 
These data indicated that the MSV spleen cells contained a subpopulation of 
radioresistant, phagocytic, carrageenan-sensitive, non-T cells, and thus probably 
macrophages or monocytes, which could suppress the proliferative response of 
lymphocytes to mitogens (reviewed in Kirchner et al.,  1976). Subsequent reports 
concerning studies of tumor-bearing rats (Glaser et al., 1975; Veit and Feldman, 
1976b), humans (Broder et al., 1975) and mice (Pope et al.,  1976) confirmed that 
suppressed responses to mitogens could be due to the presence of a population of 
suppressor macrophages. In addition to the suppression' of mitogen responses, 
macrophage-mediated suppressive effects have been demonstrated in a variety of 
other in v i tro  reactions. Fernbach et al. (1976b) found that MSV spleen cells 
responded poorly to alloantigens in MLC and CML. When mixed with normal mouse 
spleen cells, irradiated MSV spleen cells were strongly suppressive compared to the 
effect of adding equal numbers of irradiated normal spleen cells. When MSV spleen 
cells were pretreated with carrageenan or when the phagocytes were depleted with 
iron and magnet, the suppressive effect was no longer seen. In addition, the cells were 
found to be adherent and radioresistant. As expected, treatment with anti-theta and 
complement had no effect. Addition of peritoneal exudate cells (PEC), induced with 
thioglycolate and purified by Petri dish adherence so that greater than 95 per cent of 
the cells were macrophages morphologically, also resulted in suppression of the MLC 
and the CML (Fernbach et al., 1976a). Berlinger et al. (1976) have shown that 
depressed MLC responses of PBL from some cancer patients could be restored by 
passing the PBL over a Sephadex G-10 column which in their hands selectively 
depleted monocytes. Kirchner et al. (1975a) found that the T cell proliferative 
response of spleen cells from tumor-bearing mice to tumor-associated antigens in a 
mixed lymphocyte-tumor interaction (MLTI) was greatly improved by depletion of 
adherent or phagocytic cells. Similarly, Glaser et al. (1975) showed that spleen cells 
taken from rats bearing progressively growing tumors were largely unresponsive to 
tumor-associated antigens in a MLTI. After depletion of adherent or phagocytic cells, 
positive responses were detected. We recently confirmed and extended these obser- 
vations, and have shown that the suppressor cells in tumor-bearing rats were resistant 
to treatment with a specific heterologous anti-rat thymocyte serum and complement 
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(ATS and C) as well as to a heterologous anti-rat immunoglubulin serum and 
complement (Oehler et al., 1977a). These data indicated that the suppressor cells in 
spleens of tumor-bearing rats which inhibit specific lymphoproliferative responses to 
tumor cells in vitro were macrophages. In rats, however, we found that normal spleen 
cells added to MLTI cultures as third parties were also suppressive, albeit not as 
suppressive as spleen cells taken from tumor-bearing donors. Extensive charac- 
terization procedures showed suppressor cells in the spleens of non-tumor-bearing 
rats similarly were macrophages. These experiments indicated that the suppressive 
nature of macrophages may not necessarily represent a pathologic state but rather 
reflect a normal regulatory mechanism which is intensified in some pathological 
conditions. 
Injection o f m i c e  with agents such as heat-killed Corynebac ter ium p a r v u m  (C. 
p a r v u m )  results in a strong stimulation of the reticuloendothelial system (RES) 
(Halpern et al., 1963; Halpern, 1975). Splenic macrophages from mice treated with C. 
parvum,  strongly supress the lymphoproliferative responses to PHA, Con A and LPS, 
and, if given in a high enough dose, to pokeweed mitogen (PWM) (Scott, 1972; 
Kirchner et al., 1975c; reviewed in Kirchner et al., 1976). Mitchell et al. (1973) have 
shown similar effects after treatment of mice with Bacillus Calmette-Guerin (BCG). 
In contrast to the inhibitory effects of suppressor macrophages on proliferative 
responses and on the generation of cytotoxic lymphocytes which require proliferation 
(Cantor and Jandinski, 1974; Peavy and Pierce, 1975), cytotoxicity by previously- 
generated effector cells seems not to be affected. Primary T cell-mediated cytotoxicity 
to tumor-associated antigens (Kirchner et al., 1974b), PHA-induced T cell-mediated 
cytotoxicity (Kirchner et al., 1975a) and antibody-dependent cell-mediated cytotoxi- 
city (Poplack et al., 1976; reviewed in Kirchner et al., 1976) appear to be unaffected by 
suppressor macrophages. Thus, immune cell functions which are independent of 
proliferation may not be sensitive to suppression by macrophages. It seems likely that 
a major mechanism of action of suppressor macrophages is inhibition of lymphocyte 
proliferation, with consequent limitation of the expansion of an antigen-sensitive 
clone of effector lymphocytes. Keller (1974a) has emphasized the need for macro- 
phages to be activated to mediate the suppressor effect. His data show that on a per 
cell.basis, peptone broth-induced rat peritoneal macrophages are more suppressive 
than non-induced peritoneal macrophages. However, in sufficient concentrations, 
'resting' or non-induced macrophages also inhibited lymphocyte proliferation (Keller, 
1974a). Our laboratory has provided further evidence, in both mice (Fernbach et al., 
1976a) and rats (Oehler et al., 1977b), that by simply increasing the concentration of 
PEC in MLC-CML cultures, lymphoproliferative responses and the resultant genera- 
tion of cytotoxic effector cells were inhibited without affecting the viability of the 
cells in the suppressed cultures. Further, the distinction between 'activated' and 
'resting' macrophages is complicated by the fact that many substances including 
lymphocyte mediators (reviewed by David, 1975), with which circulating macrophages 
must to a variable degree be in contact in vivo, activate macrophages. Therefore, it 
may be better to think of relative degrees of activation rather than of an all or none 
phenomenon. This would account for both Keller's (1974a) findings that activated 
macrophages were more suppressive than resting (less activated) macrophages and 
our observations that increased numbers of peritoneal macrophages added to CML 
cultures as third parties [5-8 per cent in rats (Oehler et al., 1977b) and greater than 10 
per cent in mice (Fernbach et al., 1976a)] were strongly suppressive. In contrast, 
addition of a thirty fold greater number of X-irradiated thymocytes to rat CML 
cultures as third parties had no suppressive effect, suggesting that cell crowding was 
not the cause of suppression by higher numbers of macrophages (Oehler et al., 1977b). 
Thus, it would appear that macrophages, either low numbers of strongly activated 
cells or higher numbers of minimally activated cells, can suppress lymphocyte 
proliferation and in that way inhibit or abrogate the expansion of a clone of sensitized 
lymphocytes. 
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3.2. MECHANISMS OF ACTION 
3.2.1. Assay Systems 
Much of the information concerning the mechanisms of macrophage-mediated 
suppression has come from the work of Keller (1974a, b, 1976; Keller et al., 1975) who 
measured the rate of proliferation of antigen- or mitogen-triggered lymphocytes in 
Petri dishes containing various concentrations of purified macrophages obtained from 
rat peritoneal exudates. Basically, Keller demonstrated that high macrophage to 
lymphocyte ratios (10:1) completely inhibited proliferation of the lymphocytes (Kel- 
ler, 1975). The effect was nonspecific in that the proliferation of syngeneic, allogeneic, 
and xenogeneic lymphocytes could be suppressed. Moreover, use of malignant 
lymphoma cells as targets of suppression has provided a consistent and simpler assay 
system for analysis of the mechanism of the macrophage-mediated suppression 
(Keller, 1974a), since these cells did not need to be stimulated to proliferate. 
Support for the use of rapidly dividing tumor cells as indicator cells for suppressor 
macrophage activity has recently been provided by our laboratory (Oehler et al., 
1977a). We have directly compared the ability of macrophages to suppress the 
proliferation rate of lymphoma lines maintained in vitro to their ability to suppress 
specific lymphoproliferative responses of immune rate splenic T cells to tumor- 
associated antigens in a mixed lymphocyte-tumor interaction (MLTI). Under the 
proper conditions, results obtained in one assay could be used to predict results 
obtained in the other. This indicated that the cytostatic mechanism was similarly 
effective on rapidly proliferating lymphoid cells regardless of the stimulus (Oehler et 
al., 1977a). 
3.2.2. Metabolic Requirements for Macrophage-Induced Suppression 
Keller (1974b) has evaluated the effects of various agents and treatments to 
determine the metabolic requirements for macrophage-induced suppression. The 
suppressive effect was sensitive only to protein synthesis inhibitors and inhibitors of 
glycolysis (Keller, 1974b). When various parameters of macrophage activity were 
monitored, such as cellular adherence, pinocytosis, bactericidal capacity, glucose 
oxidation, production of RNase and DNase, and others, only alterations in the rate of 
protein synthesis correlated with the cytostatic effects observed (Keller, 1975). 
Pretreatment of macrophage monolayers with inhibitors of DNA synthesis such as 
mitomycin C and X-irradiation had no effect on their cytostatic activity. In addition, 
the suppressor activity was resistant to treatment with a variety of enzymes including 
trypsin, neuraminidase and pronase. Inhibitors of pinocytosis or phagocytosis had no 
effect. Moreover, careful microscopic examination of the experimental cultures 
showed no relationship of increased phagocytic activity to the degree of suppression. 
Thus, although the mechanisms by which macrophages inhibit lymphoproliferative 
responses are unknown, the available evidence suggests that the ability to suppress 
can be correlated with the rate of protein synthesis and not with various other 
parameters of macrophage activation. This could be interpreted to suggest that only a 
subpopulation of macrophages, characterized by its increased rate of protein syn- 
thesis, is suppressive or that only macrophages which have been activated to undergo 
increased protein synthesis are suppressive. However, until these findings are 
confirmed in other laboratories, it may be premature to speculate on the mechanisms by 
which suppressor macrophages mediate their effects. 
3.2.3. Suppressor Effects of Macrophages Mediated by Soluble Factors 
Although there are a number of reports describing suppressor effects of macro- 
phages which require cell-cell contact (Sj6berg and Britton, 1972; Sj/Sberg, 1971; 
Eggers and Wunderlich, 1975; Kirchner et al., 1975a; reviewed in Kirchner et al., 
1976), macrophages also appear to mediate suppressor effects through the effects of 
soluble factors (for review see Modulation of Immunity by Soluble Mediators by 
Byron H. Waksman, in this series). Suppressor factors produced bY or dependent on 
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macrophages have been described by a number of investigators. Calderon et al. (1974) 
have described a factor recovered from cultures of mouse peritoneal exudate cells 
which inhibited 3H-TdR incorporation by, and proliferation of, tumor cells and 
mitogen-stimulated lymphocytes in vitro. It was of low molecular weight and resistant 
to trypsin digestion. Further, it could be absorbed by tumor cells cultured in vitro. 
Similarly, Waldman and Gottleib (1973) have described a low molecular weight factor 
isolated from rat PEC which inhibited proliferation of antigen-stimulated and resting 
rat lymphocytes. Krakauer et al. (1976) have demonstrated a soluble suppressor factor 
which inhibited immunoglobulin production of PWM-stimulated mouse spleen cells. 
This factor was apparently produced by macrophages in the ascitic fluid of hypo- 
gammaglobulinemic mice bearing plasmacytomas. Similarly, Kolb et al. (1977) have 
demonstrated a suppressor factor apparently originating from macrophages of mice 
bearing large plasmacytomas which inhibited the PFC response to SRBC in Mishell- 
Dutton cultures. 
Caution must be exercised, however, in evaluating the effects of soluble factors 
produced from lymphoid cells in tissue culture. When only one parameter such as 
3H-TdR incorporation is used as a measure of suppression, the possibility that 
breakdown products of dying cells are present in the culture which compete with 
radiolabeled DNA precursors and thus inhibit 3H-TdR incorporation without inhibit- 
ing cell proliferation must be ruled out. One group (Opitz et al., 1975a), in fact, has 
performed a series of biochemical characterizations on a soluble factor which they 
had previously shown to suppress 3H-TdR incorporation of PHA-stimulated mouse 
lymphocytes (Opitz et al., 1975b) and conclusively demonstrated that it was thy- 
midine. There are several ways to avoid such tissue culture artifacts. One way is to 
use a second assay system independent of 3H-TdR incorporation to demonstrate the 
suppressive effect. Fernbach et al. (1976a) showed that macrophages suppressed the 
generation of cytotoxic effector cells and the appearance of blast cells as well as the 
incorporation .of 3H-TdR by mouse T cells in MLC. In this study, by observing the 
effects of various concentrations of macrophages on the MLC, they noted that 
3H TdR incorporation was inhibited at a slightly lower concentration of macro- 
phages than was the generation of lymphoblasts or the generation of cytotoxic 
effector cells. It seems likely that the slightly disparate findings were a result of the 
presence of cell breakdown products in the media. This effect, however, was minor 
compared to the effect of greater numbers of macrophages which totally suppressed 
all three parameters of the response generated in the MLC. 
In addition to using alternate assay systems, one can measure the incorporation of 
other labeled protein or nucleic acid precursors such as tritiated uridine, valine or 
leucine. Opitz et al. (1975a) showed that the incorporation of these precursors was not 
inhibited by supernatants from cultures containing cell breakdown products which 
artifactually inhibited 3H-TdR incorporation. Similarly, Fernbach et al. (1976a) have 
suggested that the use of low specific activity 3H-TdR (300mCi/mM instead of 
6 Ci/mM) minimized the effect of artifactual 3H-TdR incorporation inhibition. Perhaps 
the easiest way to avoid such artifacts is to wash the cells immediately before addition 
of 3H-TdR, thus removing any cell breakdown products which may have accumulated 
during the culture period. 
Thus, in light of the findings of Opitz et al. (1975a), who identified their low 
molecular weight suppressor factor as thymidine, it seems mandatory that any soluble 
suppressor substance which inhibits 3H-TdR incorporation of proliferating cells in 
vitro must be shown to actually inhibit cellular proliferation to be seriously con- 
sidered as a factor which may have immunosuppressive activity in vivo. 
3.2.4. M a c r o p h a g e  Ac t iva t ion  as a Resul t  o f  Interact ion with Exogenous  Agen t s  or 
with L y m p h o c y t e s  and Their  Mediators  
As previously discussed, macrophages which are in states of increased activation, 
usually associated with increased rates of protein synthesis, are more suppressive on 
a per cell basis than less activated macrophages. A number of agents are known to 
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stimulate the reticuloendothelial system (RES) which results in the appearance of 
highly activated macrophages in the organs of the lymphoid system and particularly in 
the spleen. Similar effects on the activation of macrophages by such agents have been 
observed in vitro. First, we will discuss exogenous agents which activate macrophages 
and the little that is known about the mechanisms involved. Then we will discuss 
possible mechanisms by which suppressor macrophage activity may be enhanced or 
regulated by interaction with lymphocytes or their mediators during the induction of 
an immune response. 
Several agents capable of activating macrophages are known. Bacterial products 
can activate macrophages. Shilo (1959) has reviewed evidence that in the case of gram 
negative bacteria, the lipopolysaccharide component of the cell wall, and particularly 
the lipid A component, is a potent macrophage activator. Other macrophage activators 
include certain organisms such as C. p a r v u m  (Halpern et al., 1964), Lis ter ia  m o n o -  
cy togenes ,  BCG, M y c o b a c t e r i u m  tuberculos is  (reviewed by McGregor and Logie, 1975) 
and double-stranded RNA (reviewed by Allison and DavieS, 1975). The actual 
mechanism of macrophage activation by these agents is unknown. C. p a r v u m  has 
been extensively studied to learn why it is such a powerful RES stimulant. Pr6vot 
(1975) has suggested that a component of the bacterial cell wall is responsible for the 
intense RES activation and has tentatively named it 'reticulostimulin'. Efforts to 
purify reticulostimulin, however, have largely resulted in abrogation of the macro- 
phage-activating effect (Adlam et al., 1975) and thus have been unsuccessful. In 
addition to microbial agents such as C. p a r v u m ,  most soluble adjuvants are known to 
stimulate reticuloendothelial proliferation and to activate macrophages (Unanue et al., 
1969a). Spitznagel and Allison (1970) have correlated the ability of various substances 
to labilize lysosomes in macrophages with their adjuvant effects. They found that 
retinoi (vitamin A alcohol) and LPS were particularly active in this respect. Despite 
the large number of empirical observations that the administration of various agents 
such as those mentioned above results in RES activation, very little is known about 
the actual mechanisms involved. It seems likely that a greater understanding of the 
mechanisms of this important aspect of the immune response will enable such agents 
to be used as one of the means of intervening in and regulating the immune response 
in the future. 
In addition to interaction with exogenous agents, macrophage-lymphocyte inter- 
actions also have been shown to result in activation of macrophages. Similar to the 
requirement for macrophages for the sensitization phase of most immune responses 
(discussed earlier in this review), macrophages have also been shown to be required to 
mediate the effector phase of the response in collaboration with sensitized lym- 
phocytes in some cases. McGregor and Koster (1971) have shown that lasting 
immunity to Lis ter ia  m o n o c y t o g e n e s  in rats can be adoptively transferred with 
thoracic duct lymphocytes, but cannot be mediated without an intact macrophage 
system. Conversely, purified macrophages from immune animals could not transfer 
lasting immunity even to intact animals. These results suggest that certain immune 
effector functions require an interaction between immune T cells and macrophages 
which neither cell alone can carry out regardless of the immune status. Nathan et al. 
(1973) have studied mediators from T lymphocytes which affect macrophages. They 
found macrophage migration inhibition factor (MIF) to be particularly active in 
increasing macrophage adherence, phagocytosis, and glucose carbon 1 oxidative 
hexose monophosphate shunt pathway metabolism. Moreover, they found that inter- 
action of macrophages with MIF also results in increased protein synthesis. Two to 
three days of exposure to the lymphokine in vitro was required before the effects 
became detectable in their system (Nathan et al., 1971). In a recent review of the 
effect of lymphocyte mediators on macrophages, David (1975) has confirmed and 
extended the reports of Nathan et al. (1973). He discussed evidence that, in addition 
to the metabolic and morphologic effects on macrophages attributed to MIF by 
Nathan et al. (1973), MIF also decreased lysosomal enzymes, increased the cyto- 
plasmic enzyme lactic dehydrogenase, as well as membrane adenylate cyclase, and 
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increased glucosamine incorporation. More importantly, bacteriostasis to Listeria 
monocytogenes and tu.moricidal activity have been shown to be strongly enhanced. 
Thus, there is ample evidence that macrophages can be activated by interaction 
with a number of agents including lymphocyte mediators, the best studied of which is 
MIF. As a result of interaction with MIF, various parameters of macrophage activa- 
tion such as the rate of protein synthesis were found to be increased. As we have 
discussed, the rate of macrophage protein synthesis correlated quite well with the 
suppressor activity of macrophages. Therefore, it is obvious that a number of agents, 
including products of activated lymphocytes (at least MIF), are capable of augmenting 
suppressor macrophage activity. 
3.3. The Relationship of  Suppressor T Cells to Suppressor Macrophages 
Recent reports of suppressor cells other than macrophages include the specific 
suppressor T cells of Tada and Taniguchi (1976) and the allotype suppressor T cells 
described by Herzenberg et al. (1976). In addition, Dutton (1972) has shown that Con 
A-stimulated T cells can nonspecifically block anti-SRBC responses in Mishell-Dutton 
culture systems in vitro. Similarly, Peavy and Pierce (1974) have used Con A- 
stimulated T cells to nonspecifically suppress the generation of cytotoxic effector cells 
to alloantigens in MLC-CML reactions. The mechanism of action in both cases is 
thought to be a suppression of the proliferative event required for the expression of 
the effector function (Dutton, 1972; Peavy and Pierce, 1974). However, these studies 
have not demonstrated whether suppressor T cells act directly on the responding 
lymphocytes or via another cell type such as a macrophage. As discussed above, 
activated macrophages (suppressor macrophages) have been shown to suppress in 
vitro lymphoproliferative reactions. Gershon (1974), in an exhaustive review of 
suppressor T cells, has allowed that the Cole of macrophages in the actual inhibition of 
proliferation resulting from suppressor T cell activity is uncertain. Recently, a 
suppressor factor has been isolated from Con A-induced suppressor T cell culture 
supernatants. This factor suppressed the generation of anti-SRBC responses in in 
vitro Mishell-Dutton cultures. The factor has been termed 'SIRS' for Soluble immune 
response suppressor (Rich and Pierce, 1974). Analysis of the factor has revealed that 
it is a glycoprotein secreted by the Con A-stimulated T cell with a molecular weight of 
48,000-67,000 daltons (Tadakuma et al. (1976a). SIRS appeared to be distinct from 
immunoglobulins in that it did not bind to immunoabsorbant columns coated with 
anti-mouse IgG or IgM (Tadakuma et a l . ,  1976a). More recently Tadakuma et al. 
(1976b) have demonstrated that SIRS acts not directly on B cells or T cells, but requires 
macrophages to mediate its effect. Thus far, SIRS has been indistinguishable from 
MIF (Tadakuma et al., 1976b). Nathan et al. (1973) have reported that MIF is a potent 
macrophage activator, causing enhanced protein synthesis. As discussed above, 
Keller (1975b) has shown that macrophage suppressor activity correlated best with the 
rate of protein synthesis as a measure of activation. Thus, it seems likely that SIRS 
may generate suppressor macrophages and thereby exert its immunosuppressive effect 
in vitro. There may not be two separate types of suppressor cells, i.e. suppressor T 
cells and suppressor macrophages, but rather the actual suppressor cell may always 
be a macrophage with T cell dependence for some forms of activation. Folch and 
Waksman (1974) have shown that normal rat spleens contain suppressor cells which 
can suppress the proliferative response in mixed leukocyte cultures. The effector cells 
mediating the suppression were adherent, but cells f rom donors having undergone 
adult thymectomy, irradiation and bone marrow reconstitution were inactive. They 
concluded that the suppressor cell was an adherent suppressor T cell. We have 
recently confirmed that normal rat spleens contain adherent cells which suppress 
MLC and CML reactivity (Oehler et al., 1977b). However, we have also shown that 
the suppressor cells are phagocytic and resistant to treatment with a specific anti-T 
cell serum and complement. Our data indicate that the final effector cell mediating the 
suppression is a macrophage. To reconcile our findings with those of Folch and 
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Waksman (1974), we have suggested that the activated macrophages in normal rat 
spleens are a reflection of, and dependent on, T cell activity in vivo (Oehler et al., 
1977c). The early findings of McGregor and Koster (1971) showing a macrophage 
requirement for the adoptive transfer by immune thoracic duct lymphocytes of 
immunity to Listeria monocytogenes may be explained in a similar manner. In this 
case, the immune T cells may have led to the gradual development of activated 
macrophages with anti-microbial activity. 
3.4. EVIDENCE THAT SUPPRESSOR MACROPHAGES CAN SUPPRESS IMMUNE RESPONSES IN VIVO 
3.4.1. Introductory Remarks  
Most of the clear-cut evidence that macrophages can act as suppressor cells comes 
from in vitro observations. It is rather difficult to directly relate such in vitro findings 
to the role of these cells in regulating the immune response in vivo. Part of this 
reflects the general problem of determining the in vivo role of in vitro phenomena. A 
classical approach in this direction has been to examine the effects of adoptive 
transfer of cells with a particular function in vitro. However, adoptive transfer of 
suppressor macrophages seems unlikely to confer a suppressed state on the recipient 
for at least two reasons. Firstly, highly activated macrophages undoubtedly do not 
stay highly activated long after transfer. Nathan et al. (1973) showed that macro- 
phages activated by lymphocyte mediators in vitro remained activated only 24-48 hr 
after removal of the activating agent. Secondly, adoptively transferred, strongly 
activated macrophages might lodge at the site of inoculation or some other unwanted 
location and not migrate into the same lymphoid microenvironment as the lym- 
phocytes engaged in the immune response or even into the appropriate lymphoid 
organs. Local adoptive transfer of macrophages, either admixed with responding 
lymphocytes or inoculated into the site of the immune response (e.g. draining lymph 
node), would be expected to overcome these problems. However, little evidence along 
these lines has been reported. The main approach which has been made to evaluate the 
in vivo role of macrophages is to administer agents which can stimulate the reticulo- 
endothelial system (RES) and cause the activation and migration of macrophages into 
the lymphoid and circulatory systems. In addition, various pathological conditions, 
both experimentally induced and naturally occurring which are associated with RES 
stimulation, present opportunities to observe the effect of strongly activated macro- 
phages in high cell densities in the proximity of lymphocytes during the generation of 
an immune response in vivo. There are a number of studies showing a depressed 
immune response in the presence of either a high macrophage cell density or a highly 
activated RES. Based in part on the in vitro evidence discussed above, one might 
predict that immune responses requiring the generation of an expanding clone of 
antigen-sensitized lymphocytes would be suppressed if sufficient suppressor macro- 
phage activity were present during the proliferative phase of the response. Inter- 
pretation of such studies, however, is complicated by the fact that the stimulating 
agents have in vivo effects other than activation of macrophages, and also that 
macrophages are involved at many levels of the immune response, both in initiating 
immune responses, i.e. antigen presentation, antigen processing, prevention of 
tolerance, and frequently in the final effector phases of the immune response, i.e. 
delayed hypersensitivity (Scott, 1974), tumor (Remington et al., 1975; Hibbs et al., 
1972; Evans and Alexander, 1972) and tissue graft rejection (Evans and Grant, 1972), 
and protection from certain infectious agents (Gadebusch, 1972). It has been possible 
to desfgn experiments to take advantage of the fact that macrophage participation in 
various phases of an immune response to an antigenic challenge do not 
necessarily occur simultaneously. Shortly after antigenic challenge, macrophages 
aid in sensitizing lymphocytes. Then, after a lag period which varies from 
24-28hr to several days, depending on the antigen, the lymphoproliferative 
phase begins, followed by the appearance of the effector phase of the immune 
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response, i.e. antibody production, cytotoxic T cell appearance, memory cell dis- 
tribution and/or macrophage activation. Thus, the lymphoproliferative phase occurs 
some time after antigen inoculation and continues through the time of the appearance 
of the effector aspect of the response. To demonstrate suppressive effects of macro- 
phage activation, the optimal time of most intense macrophage activation should be 
during the proliferative phase, i.e. some time after antigen inoculation and before the 
appearance of effector cells (plasma cells or cytotoxic T ceils). Similar to the kinetics 
of the immune response, the length of time between injection of a stimulating agent 
and the appearance of maximal macrophage activation must be taken into account. 
The kinetics of the appearance of suppressor macrophages in the spleen of experi- 
mental animals differs slightly with the particular activating agent used, the dose and 
the route of administration. 
Thus the most convincing evidence that suppressor macrophages can inhibit the 
generation of an immune response in vivo would come from experiments in which 
suppressor macrophages and few proliferating lymphocytes have been shown to be in 
lymphoid organs at the time when one would expect the lymphoproliferative phase of 
the immune response to be occurring. Ideally, one might then find that upon removal 
of inactivation of suppressor macrophages, fully immunocompetent lymphocytes 
remain. In addition, in vivo administration of agents which inactivate macrophages 
without interfering with their numerous enhancing effects would be expected to 
reverse the immunosuppression. Such evidence would point to suppressor macro- 
phages as the main or only cause for the suppressed immune response observed in 
vivo. 
In the sections to follow, we shall review the available evidence for in vivo 
suppression of immune responses by macrophages. In addition, evidence will be 
reviewed regarding the possibility that some forms of antigenic competition may be 
due to the appearance of splenic suppressor macrophages. 
3.4.2. Suppression Directly Related to Macrophage Concentration In Vivo 
A simple but still somewhat artificial way to observe the effects of local adoptive 
transfer of high macrophage concentrations on antigen-triggered lymphocytes in vivo 
would be to place antigen-primed lymphocytes in a small Millipore chamber with the 
antigen and a large number of macrophages, and implant the chamber into the 
peritoneal cavity of a lethally irradiated histocompatible mouse. Measurement of the 
resultant serum and chamber antibody levels and comparison with levels generated in 
mice in which similar chambers were implanted without high numbers of macrophages 
would give some indication of the effect of the extra macrophages. 
Using such an experimental design, Perkins and Makinodan (1965) placed SRBC- 
primed mouse spleen cells in 0.1/~m Milliport chambers with SRBC and various 
numbers of peritoneal exudate cells and implanted them in irradiated mice. As 
controls, they implanted chambers to which they added either unprimed mouse spleen 
cells in numbers equal to the primed responding cells plus SRBC or primed respond- 
ing cells plus SRBC alone. After 9 days, they measured the hemolysin titer in both the 
chamber fluid and the serum. The antibody titers from mice bearing chambers 
containing primed spleen cells plus SRBC were very similar to those with primed 
spleen cells, SRBC and  equal numbers of unprimed spleen cells. In contrast, the 
chamber fluid or sera from mice bearing chambers containing additional PEC 
sufficient to make up 20-30 per cent of the primed responding cell had markedly 
depressed titers. No concentration of PEC produced enhanced antibody production 
and high numbers of PEC completely suppressed the response. To reduce the 
artificiality of the approach with Millipore chambers, similar experiments were de- 
signed in which mice were injected intraperitoneally with glycogen to increase the 
number and the level of activation of the peritoneal macrophages, or only with saline. 
Both groups were challenged with SRBC i.p. and the serum hemolysin titers measured 
every other day for 10 days. At all time points tested, mice pretreated with glycogen 
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had lower serum antibody levels compared to the saline-injected controls. The 
objective of these experiments was to obtain in vivo data to. support the notion that 
macrophages enhanced the SRBC response, but the results which were in the opposite 
direction indicated that high cell densities of macrophages in the environment of 
lymphocytes which were stimulated to proliferate and produce antibody could sup- 
press antibody production in vivo. Hoffman (1970), using an in vitro Mishell-Dutton 
culture system, obtained similar results and, in addition, provided evidence that the 
suppressive effect of the high concentration of macrophages was mediated through an 
inhibition of the proliferative phase of the response. He found that the optimal 
macrophage concentration for an in vitro SRBC response was 2 per cent of the 
responding spleen cells. Adding purified peritoneal macrophages to a final concen- 
tration of 20 per cent of the responding spleen cell population resulted in profound 
inhibition of the response. Moreover, analysis of the cells in the suppressed cultures 
revealed greatly decreased blastogenesis and plasma cell formation. He postulated 
that the high concentration of macrophages inhibited the proliferation of antigen- 
sensitive cells, thereby preventing a clonal expansion of cells destined to produce 
antibody. Alternatively, since T cells are also required to provide a helper factor for 
the production of antibody to heterologous erythrocytes, both in vitro and in vivo 
(reviewed in Oppenheim and Rosenstreich, 1976; Katz and Benacerraf, 1972), the 
suppressive effect of macrophages could have been mediated through inhibition of the 
T cell response. However, there is little if any evidence that macrophages can 
suppress the production and release of factors per se. So this alternative seems 
unlikely. Moreover, evidence has been presented that suppressor macrophages can 
inhibit LPS-induced B cell proliferative responses in mice (Kirchner et al., 1974b) and 
rats (Yoshinaga et al., 1972). Since LPS induces B cell proliferation directly without 
the aid of accessory cells (Lipsky and Rosenthal, 1976; reviewed by Oppenheim and 
Rosenstreich, 1976), it would appear that macrophages are capable of suppressing B 
cell proliferation directly. Thus, it is likely that the suppression by high concentrations 
of macrophages of antibody production in the above cases was due to inhibition of 
proliferation of the antigen-sensitized clone of B cells. 
3.4.3. Suppression of  Antibody Production In Vivo by a Macrophage-Activating 
Agent 
Lipopolysaccharide has been shown to activate macrophages (see Section 3.2.4) and 
in vivo inoculation of this material has been shown to inhibit immune responsiveness 
(Bradley and Watson, 1964; Franzl and McMaster, 1968). As predicted above, the 
demonstration of LPS-induced suppression is very dependent on the time of adminis- 
tration of LPS in relation to antigen inoculation. It seems necessary for the LPS to 
come in contact with macrophages which are closely associated with lymphoid cells 
prior to exposure to antigen. In other words, if LPS and the antigen (SRBC) were 
given by the same route, the LPS had to be given 24-48 hr prior to the antigen. Only 
relatively large doses of LPS induced suppression when given i.p. 24 hr before antigen 
inoculation into the same area. If LPS was given i.v. 24 hr before antigen i.p., five-fold 
less endotoxin could totally abrogate the anti-SRBC response (Franzl and McMaster, 
1968). Similarly, Bradley and Watson (1964) have shown that a relatively large dose of 
LPS given to mice at the time of injection of actinophage MSP8 simply delayed the 
production of neutralizing antibody, whereas daily injections of LPS suppressed the 
antibody production indefinitely despite continued presence of the phage in the tissues 
of the animal. Further, hyperimmunized mice with high levels of circulating antibody 
could be suppressed with daily LPS administration. When the LPS was stopped, the 
antibody production resumed as indicated by the prompt appearance of high serum 
levels of neutralizing antibody. The results of these studies indicate that antibody 
production in mice can be suppressed by an agent which activates macrophages. 
However, it is possible that the inhibitory effects of LPS are independent of 
macrophages, since as noted above, LPS can have direct effects on B cells. 
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3.4.4. The Suppressive Effect of C. parvum on the Generation of  Resistance to Tumor  
Cells 
C. parvum is a powerful RES-activating agent (Halpern et al., 1963) which can induce 
splenic suppressor macrophages in mice (Kirchner et al., 1975c; Scott, 1972). 
Similarly, C. parvum injection has been shown to suppress some immune responses 
requiring proliferation in vivo. Immunization procedures which normally conferred a 
significant amount of protection from tumor challenge were much less effective if 
instituted 4-5 days after C. parvum injection (Smith and Scott, 1972; Woodruff et al., 
1976). The studies of Scott (1972) demonstrated the temporal relationship between C. 
parvum injection and the appearance of suppressor macrophages. Intravenous in- 
oculation of C. parvum produced maximal suppression of responsiveness of spleen 
cells to PHA at day 7, with some persisting inhibition through day 28. This sup- 
pression was shown to be mediated by macrophages. Considering this time course for 
the appearance of suppressor cells in the spleen after C. parvum injection, one might 
predict that immune responses generated in the spleen and dependent upon the rapid 
expansion of an antigen-sensitized clone of lymphocytes would be suppressed if the 
proliferative response occurred about 7 days after C. parvum injection. Thereafter 
(for at least 2 weeks) moderate suppression might be observed. Smith and Scott (1972) 
investigated the protective effects of C. parvum injection on challenge of CBA mice 
with R-1 leukemia cells (a radiation-induced syngeneic leukemia). Inoculation of 
unimmunized mice with as few as ten tumor cells i.p. resulted in the death of all 
recipients with 10--15 days. When mice were immunized with a single dose of 1 x 105 
heavily irradiated R-1 cells 7 days prior to the inoculation of 100 R-1 cells i.p., 50 per 
cent of the mice survived. When C. parvum was given 7 days before the immunizing 
dose of irradiated R-1 cells, 90 per cent of the mice died within 20 days of the 
injection of non-irradiated R-1 cells. Similarly, Woodruff et al. (1976) have reported 
that in CBA mice, protection against a syngeneic chemically induced fibrosarcoma by 
immunization with irradiated tumor cells was decreased by pretreatment with C. 
parvum 5 days before the immunizing dose. Recent studies in our laboratory by 
Kirchner et al. (1975b) have provided insight into possible mechanisms operative in 
the experiments described above. C56BL/6 mice injected with Moloney sarcoma virus 
developed a tumor at the site of inoculation which reached maximum size 14 days 
after inoculation and regressed completely by 21 days (MSV mouse tumor system). 
Spleen cells taken from donors after tumor regression could be stimulated to become 
cytotoxic in vitro by cocultivation with mitomycin C-treated RBL-5 tumor cells, 
shown to contain relevant antigens (Herberman et al., 1974). To test the effect of C. 
parvum inoculation in this system, mice were given C. parvum i.p. 23 days after virus 
infection, and 7 days later primed spleen cells from these mice were cultured in vitro 
with RBL-5 to generate cytotoxic effector cells. The cytotoxicity generated with such 
cells was much lower than that generated with spleen cells from immune mice not 
treated with C. parvum. This effect of C. parvum appeared to be mediated by 
suppressor macrophages, since mixture of immune spleen cells with spleen cells from 
mice inoculated 8-10 days earlier with C. parvum resulted in a marked suppression of 
generation of cytotoxicity. The suppression by the spleen cells from C. parvum- 
treated mice was dependent on the presence of macrophages but not T cells. 
Bernstein et al. (1977) have recently shown that the generation of cytotoxic effector 
cells from non-cytotoxic primed rat spleen cells required the proliferation of a clone 
of lymphocytes during cocultivation with mitomycin-treated (C58NT)D tumor cells. 
Similarly, our laboratory has provided evidence that a proliferative response is also 
required for the generation of cytotoxic effector cells in vitro from non-cytotoxic 
primed cells in the MSV mouse tumor system (Stiller, Holden and Herberman, 
unpublished observations). Thus it seems likely that the suppressed cytotoxic re- 
sponse generated in vitro by C. parvum-pretreated MSV immune mice was due to the 
inhibition of the required lymphoproliferative response by the C. parvum-induced 
suppressor macrophages. These observations by no means prove that the interference 
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with tumor resistance (Smith and Scott, 1972; Woodruff et al., 1976) was caused by 
the inhibition of a proliferative response required to generate an immune state, but the 
similarities between'the in vivo observations and the in vitro findings are striking. An 
important issue is whether the increased numbers of activated macrophages found in 
the spleens of animals treated with C. parvum (or other RES stimulants) can inhibit 
lymphoproliferative responses sufficiently to suppress in vivo generation of cytotoxic 
effector cells. Evidence that spleens of C. parvum-treated mice can inhibit the 
proliferation of antigen-stimulated lymphoid ceils in vivo has been provided by 
Howard et al. (1967). They treated Ft hybrid mice with i.v.C, parvum 4 days before 
i.v. injection of 108 viable parental lymphoid cells, thus initiating a graft versus host 
(GVH) reaction in the environment of a highly stimulated reticuloendothelial system. 
The pretreatment with C. parvum protected the majority of the mice from the 
uniformly fatal GVH reaction which occurred in the untreated control mice. Evidence 
for the mechanism of action of the protective effect was obtained by examining the 
spleens of representative mice from each group for proliferating lymphocytes. Twelve 
days after GVH initiation, the percentage of donor cells in mitosis was 85-90 per cent 
in the untreated Fj hybrid recipients. In contrast, only 0--5 per cent of the proliferating 
cells were of donor origin in the mice pretreated with C. parvum. These data show 
that C. parvum induced an environment in the spleens of mice which suppressed 
rapidly-proliferating alloantigen-stimulated parental lymphoid cells in vivo. It remains 
to be directly demonstrated that macrophages were in fact responsible for the 
anti-proliferative effect. 
C. parvum and other potent RES stimulators are frequently used as im- 
munotherapeutic agents to increase resistance against tumor growth. However, the 
observations discussed above indicate that, under some circumstances, these agents 
may actually interfere with effective anti-tumor immunity and that these immunosup- 
pressive effects may be mediated by suppressor macrophages. 
3.4.5. The Possible Role of  Suppressor Macrophages in Antigenic Competit ion 
The interference with the immune response to an antigen by prior inoculation with 
high doses of a non-cross-reactive second antigen has been termed antigenic com- 
petition. Antigenic competition has been extensively studied and the subject has been 
thoroughly reviewed recently (Pross and Eidinger, 1974). As suggested by Pross and 
Eidinger (1974), it seems likely that numerous mechanisms of action are responsible 
for the various phenomena grouped under the heading of antigenic competition. Since 
some instances of antigenic competition can actually be shown to be suppressive 
phenomena and the suppression is at least associated with an inhibition of proli- 
ferative response, suppressor macrophages should be considered as one type of 
mediator of these effects. 
Several lines of evidence suggest that some forms of antigenic competition may 
actually be mediated through a suppressor mechanism rather than direct competition 
between antigens for responding cells. Sj6berg and Britton (1972) have shown that 
spleen cells from mice heavily preimmunized with SRBC suppressed the PFU 
response of normal mouse spleen cells to horse red blood cells (HRBC) when 
cocultivated in Mishell-Dutton culture systems in the presence of SRBC. Similarly, 
Thomas et al. (1975) have shown that when spleen cells from mice immunized with 
ovalbumin (OVA) were added with OVA to Misheli-Dutton cultures with SRBC- 
primed spleen cells the SRBC-specific PFU response was suppressed compared to 
cultures in which either the OVA or the OVA immune spleen cells were omitted. 
Further, Thomas et al. (1975) reported that in suppressed cultures, 3H-TdR incor- 
poration was depressed compared to nonsuppressed control cultures, indicating that 
the mechanism of the suppressor effect involved the proliferation rate of the respond- 
ing cells. M611er (1971a) has presented evidence that DNA synthesis in the spleen of 
mice subjected to antigenic competition is reduced compared to normal controls. 
When mice were preimmunized by two injections of HRBC and then irradiated with 
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900r before receiving normal spleen cells in adoptive transfer, the rate of DNA 
synthesis in the spleen as determined by '25IUdR incorporation in vivo was suppressed 
by 40-50 per cent when compared to unimmunized but otherwise similarly treated 
control mice. Whether T cells or B cells were preferentially suppressed in these 
systems was not tested. However, there is evidence that the suppressive effect can be 
observed on either population. Although it is generally accepted that the induction of 
antigenic competition requires injection of a T-dependent antigen (reviewed in Pross 
and Eidinger, 1974), the antibody response to T-independent antigens was shown to be 
susceptible to suppression (Sj6berg and Britton, 1972), suggesting that B cells could 
be suppressed directly. On the other hand, Bash et al. (1976) have shown that spleen 
cells from rats injected 24 hr earlier with large doses of OVA i.v. responded poorly to 
PHA compared to normal controls, and when mixed with normal spleen cells, these 
cells were highly suppressive. The experiments showed that the suppressive effect on 
proliferation in vitro could also affect T cells. The apparent lack of specificity of the 
suppressor effect is consistent with the nonspecific nature of suppressor macrophage 
activity (reviewed by Kirchner et al., 1976). Bash et al. (1976) have shown that the 
suppressor cell activated by injection of large doses of OVA is adherent and 
somewhat sensitive to carrageenan [a specific macrophage toxin (Lake et al., 1971)]. 
However, since low doses of cyclophosphamide given i.p. at the time of antigen 
administration in vivo also abrogated the suppressor effect, the authors concluded that 
T cells and macrophages acted synergistically to be suppressive. Thomas et al. (1975) 
have shown that the suppression of AFC production in vitro by OVA immune mouse 
spleen cells cultured in the presence of OVA was mediated by a soluble suppressor 
factor produced by T cells. The characteristics of the factor are not unlike those of 
'SIRS', another soluble suppressor described by Rich and Pierce (1974) and charac- 
terized by Tadakuma et al. (1976). SIRS, as discussed above (Section 3.3), is a product 
of Con A-stimulated T cells which can nonspecifically suppress AFC production to 
heterologous erythrocytes in vitro. The mechanism of action has to some extent been 
elucidated in that the target cell has been shown to be a macrophage in the responding 
cell population (Tadakuma et al., 1976). Thus, the role of suppressor macrophages in 
the experiments reported by Thomas et al. (1975) would seem to require further 
investigation. 
In summary, although the mechanisms for antigenic competition are largely un- 
known and may be quite heterogeneous, in the instances in which suppression of 
proliferation is associated with the depressed response, it seems likely that suppressor 
macrophages activated by antigen-stimulated T cells or their products play a role. 
3.4.6. The Role o f  Macrophages in Immunosuppress ion Associa ted  with Graft  Versus 
Hos t  Disease 
In mice, antibody responses to SRBC have been shown to be greatly suppressed in 
vivo after induction of chronic GVH disease (Blanden, 1969; M611er, 1971b). Blanden 
(1969) also has shown that in mice undergoing mild chronic GVH, immunization with 
KLH in complete Freund's adjuvant was virtually ineffective, as indicated by a 
greatly depressed immediate hypersensitivity reaction upon challenge with antigen. 
Similarly, PFtJ responses generated in vivo to T-independent antigens have also been 
shown to be suppressed in mice undergoing chronic GVH. In contrast to the 
decreased humoral response to the various types of antigens (cellular, soluble, 
T-dependent and T-independent), the resistance of such mice to infection with 
Listeria rnonocytogenes was significantly increased (Blanden, 1969). Such increased 
resistance has frequently been associated with elevated levels of macrophage activity 
(McGregor and Koster, 1971). As discussed earlier, states of increased macrophage 
activation in vivo have occasionally been associated with immunosuppressive effects. 
One might therefore predict that normal syngeneic lymphoid cells adoptively trans- 
ferred into irradiated animals undergoing chronic GVH disease would be im- 
munosuppressed. M611er (1971b) has shown that this is indeed the case. He found that 
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both primed and normal spleen cells when adoptively transferred into irradiated F~ 
mice undergoing chronic GVH disease had strongly suppressed antibody responses to 
i.v. SRBC when compared to irradiated and adoptively transferred but otherwise 
normal FI control recipients. Byfield et al. (1973) showed that viable parental T cells 
were required in the cells injected to induce GVH disease-related suppression of the 
response to SIII. However, certain aspects of their findings led them to postulate that 
macrophages, perhaps activated in response to the alloantigen-stimulated parental T 
cells, in fact directly mediated the suppressor effect. This was supported by the 
findings of Sj6berg (1971, 1972). He has shown that spleens taken from FI hybrid 
donors 1 week after induction of GVH disease (GVH spleen cells) were essentially 
unresponsive to SRBC in MishelI-Dutton cultures. Moreover, when GVH spleen cells 
were added to normal or primed Fj or parental spleen cells with SRBC, the response 
was strongly suppressed compared to F~ or parental spleen cells cultured with SRBC 
alone (Sj6berg, 1971). The media from suppressed cultures could support strong 
anti-SRBC responses of normal spleen cells, indicating the suppression was not due to 
media exhaustion or a stable soluble factor. Pretreatment of the GVH spleen cells 
with anti-theta and complement before mixing with normal cells did not abrogate the 
suppressor activity. Depletion of phagocytes from the GVH spleen cells with iron and 
magnet treatment did abrogate the suppressor effect, indicating that the suppressor 
cell was a macrophage (Sj6berg, 1972). Thus, taken together, the findings of Byfield et 
al. (1973) and Sj/Sberg (1971, 1972) provided further evidence that in some cases, 
suppressor macrophages can be generated in response to activated T cells. 
In addition to the suppressed humoral responses observed in chronic GVH disease, 
cellular reactions have also been shown to be suppressed. Lapp and M611er (1969) 
have shown that skin grafts from allogeneic mice survived significantly longer when 
grafted to unrelated F~ hybrid recipients undergoing GVH disease. Both primary and 
secondary set rejection times could be delayed. However, the mechanism for this 
immune suppression has not been extensively studied. 
Chronic GVH disease then appears to be another example of a situation in which 
suppressed immune responses can be demonstrated in vivo and in which the sup- 
pression of the responses in vitro can be shown to be mediated by macrophages. 
Further, as in the case of antigenic competition, it seems likely that the suppressor 
macrophages are T cell-dependent. 
3.4.7. The Role o f  Macrophages in Immunosuppress ion Associated with Cancer and 
Other Pathological Conditions 
Cancer, miliary tuberculosis, sarcoidosis, lepromatous leprosy and severe viral 
illnesses are among those diseases associated with depressed humoral and cellular 
responsiveness (Hersh. et al., 1973; Smith, 1972; Turk and Waters, 1971). Patients with 
advanced cancer have long been known to have suppressed delayed hypersensitivity 
responses when skin tested with tuberculin (Renaud, 1926), mumps (Logan, 1956; 
Lamb et al., 1962) and other microbial antigens (Logan, 1956; Lamb et al., 1962; Solowey 
and Rappaport, 1965). In addition, there is evidence that some cancer patients have a 
delayed rejection of allogeneic grafts of skin and tumor cells (Gardner and Preston, 
1962). Lee et al. (1970) were able to demonstrate significant impairment of the ability of 
non-lymphoid cancer patients to generate serum levels of antibody to flagellin from 
Salmonella adelaide when compared to the response of ag~-matched, hospitalized 
patients with diseases thought not to have immunosuppressive" effects. Whether such 
depressed cellular and humoral immune responses precede and perhaps play an etiologic 
role in these conditions, or are a result of them is uncertain. In the case of cancer patients, 
however, the demonstration of an anergic state is frequently associated with a poor 
prognosis (reviewed by Hersh et al., 1973). Thus, insight into the mechanisms resulting in 
such disease-related immunosuppression could be helpful in developing a more 
sophisticated approach to the medical management of this group of patients. 
Patients with multiple myeloma frequently have suppressed serum levels of normal 
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immunoglobulin, respond poorly to antigenic stimulation, and are highly susceptible to 
infection (Fahey et al., 1963; Broder et al., 1975). Broder et al. (1975) have shown that 
PBL from multiple myeloma patients cultured in vitro with pokeweed mitogen 
(PWM) synthesized significantly less immunoglobulin than PBL from normal volun- 
teers under similar conditions. In addition, in many cases, PBL from multiple 
myeloma patients, when added to normal PBL, suppressed their immunoglobulin 
synthesis in response to PWM. When phagocytic mononuclear ceils were depleted 
from the PBL of the multiple myeloma patients, the ability to suppress normal PBL 
immunoglobulin synthesis in response to PWM was largely abrogated. Moreover, the 
response of PBLs of a myeloma patient to PWM was greatly improved by removal of 
phagocytic cells. PWM induces a blastogenic response in both T cells and B cells 
(reviewed by Oppenheim and Rosenstreich, 1976) and X-irradiation of human B cells 
prior to culture with PWM prevents the appearance of immunoglobulin in the media (T. 
Waldmann, personal communication). These findings suggest that monocytes in the 
PBL of some myeloma patients can suppress the proliferation and immunoglobulin 
production of human B cells in vitro. Similarly, in a rodent plasmacytoma model 
(Krakauer et al., 1976), ascitic fluid from tumor-bearing hypogammaglobulinemic mice 
was found to contain a low molecular weight trypsin-sensitive factor which sup- 
pressed PWM-induced immunoglobulin synthesis by normal mouse spleen cells or 
human PBL. When the ascites from such mice was depleted of phagocytic cells, the 
suppressor factor could no longer be demonstrated. Similarly, Kolb et al. (1977) have 
found that macrophages in the spleens taken from hypogammaglobulinemic mice 
bearing large plasmacy.tomas suppressed the PFC response of normal spleen cells to 
SRBC in a Mishell-Dutton culture gystem when added in as third parties. These 
studies taken together provide evidence that in both mice and humans suppressor 
macrophages and/or their products can suppress the production of immunoglobulin by 
B cells from normal or tumor-bearing individuals in v i tro.  These findings are con- 
sistent with the findings of Kirchner et al. (1976) and others (Yoshinaga et al., 1972) 
that in animal systems, B cell mitogen-induced proliferative responses can be sup- 
pressed by suppressor macrophages. 
Allogeneic skin graft survival was prolonged on some patients bearing malignant 
neoplasms (Gardner and Preston, 1962). A number of in vitro observations of 
suppressed MLC responses using cells from cancer patients have provided evidence 
that suppressor macrophages may be involved in this form of immunosuppression 
also. Berlinger et al. (1976) have compared MLC reactivity of PBL from patients with 
solid, non-lymphoid malignancies to the reactivity of PBL from normal donors. They 
were able to identify a group of cancer patients in whom MLC reactivity was 
consistently depressed compared to normal controls. When the PBL with suppressed 
responsiveness were passed through a Sephadex G-10  column which selectively 
depleted monocytes, the MLC reactivity was improved in all cases which were 
suppressed. When PBL from normal donors were similarly filtered, no such effect was 
seen. Our laboratory (Jerrells~ Dean and Herberman, unpublished observations) has 
confirmed that the lymphoproliferative responses of some cancer patients to mitog~ns 
or to allogeneic PBL could be significantly increased by passage of their PBL over 
Sephadex G-10 columns. Furthermore, the addition of mitomycin C-treated PBL 
from these patients to cultures of normal PBL could significantly inhibit proliferative 
responses to T cell mitogens. However, this mechanism does not appear to account 
for the depressed lymphoproliferative responses of all such patients, since in some 
cases, the responses remained depressed after removal of adherent cells. Twomey et 
al. (1975) have shown that PBL from patients with Hodgkin's disease stimulated 
normal PBL poorly in MLCs. When adherent cells were depleted from the patients' 
cells used as stimulators, strong MLC responses were observed. They could show that 
the suppressor cell was radioresistant and required protein synthesis to be sup- 
pressive, but their failure to show the cell was phagocytic using a 'modified technique' 
led them to postulate that the suppressor cell was a lymphocyte similar to that 
observed in normal rat spleen cells by Folch and Waksman (1974). As discussed 
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earlier, recent evidence suggests that the cells described by Folch and Waksman were 
actually T cell-dependent suppressor macrophages. Thus it is possible that the findings 
of Twomey et al. (1975) may also support the notion that suppressor macrophages 
from PBL of cancer patients can suppress the proliferative phase of the response to 
alloantigens in vitro. 
Studies in experimental animal tumor systems have provided a firm basis for the 
role of suppressor macrophages in the immunodepression of tumor-bearing in- 
dividuals. Our laboratory (Fernbach et al., 1976b) has shown that spleen cells from 
mice bearing MSV-induced tumors responded poorly in MLC and CML reactions. As 
described earlier, these depressed responses were shown to be mediated by sup- 
pressor macrophages. Veit and Feldman (1976a) have studied a rat tumor model in 
which they found suppressed MLC responsiveness with spleen cells from tumor- 
bearing rats. Extensive cell characterization procedures identified the suppressor cells 
as macrophages (Veit and Feldman, 1976b). Eggers and Wunderlich (1975) have 
provided evidence that spleen cells from mice bearing a methylcholanthrene-induced 
tumor also contained suppressor macrophages which suppressed the in vitro genera- 
tion of cytotoxic effector cells to alloantigens. In contrast, Fujimoto et al. (1976a) 
have reported that when mice bearing methylcholanthrene-induced tumors served as 
donors of thymocytes to be adoptively transferred to syngeneic mice just prior to 
tumor inoculation, the rate of eventual tumor regression was slowed. Since thy- 
mocytes treated with anti-theta and complement had no such effect, Fujimoto et al. 
(1976b) concluded that the suppressor cells were T cells. However, since survival 
rates of the 'suppressed' and the nonsuppressed groups were identical, despite 
significant (19 < 0.001) differences in the rate of tumor regression, it is difficult to draw 
firm conclusions from these experiments. Further, since all of the experiments were 
performed in vivo, the mechanism of the enhanced tumor growth, i.e. whether 
mediated through suppressor macrophages and acting on the immune response to the 
tumor or by direct enhancement of the growth of the tumor, would seem to be an 
open question. 
Thus, suppressed T cell responses to alloantigens have been demonstrated in a 
variety of tumor systems. In mice, rats and humans, suppressed MLC responses have 
been shown to be due to cells which have been characterized as monocytes or 
macrophages by a number of criteria. Spontaneously occurring tumors as well as 
tumors induced by virus infection and carcinogen inoculation have been shown to 
induce suppressor monocytes or macrophages in the PBL of humans or spleen of 
mice and rats which can suppress reactivity to alloantigens. Therefore, these in vitro 
findings provide at least one possible explanation for the observations that allogeneic 
skin graft survival is prolonged in cancer patients. It would seem that further 
investigations designed to clearly define the role of suppressor macrophages in 
suppression of immune responses to alloantigens in vivo are indicated. 
In addition to cancer, certain infectious diseases are known to be associated with 
suppression of immune responses. Generally, the degree of immunosuppression has 
correlated with the severity of the disease. The cause and effect relationship between 
the phenomena is an important question to be answered. Leprosy, a human disease 
caused by infection with Mycobac te r ium leprae, has provided insight into the cor- 
relation of immunosuppression with the severity of disease. Turk and Waters (1971) 
studied histological sections of lymph nodes taken from patients with leprosy varying 
in severity from tuberculoid leprosy (with the best prognosis), through borderline 
leprosy (an intermediate stage), to l epromatous  leprosy (disseminated disease). 
Tuberculoid  leprosy was associated either with a completely normal appearing lymph 
node or with nodes demonstrating a lymphocytosis of the paracortical areas [generally 
considered to be thymus-dependent (Parrot and Desousa, 1971)]. Occasionally, lym- 
phoblasts were noted in the paracortical areas, indicating the presence of ongoing 
lymphoproliferative responses. These patients responded well to intradermal lepromin 
testing and could be sensitized to dinitrochlorobenzene (DNCB). Lymph nodes from 
patients with leprosy of intermediate severity showed an infiltration of the paracorti- 
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cal regions with epithelioid-like cells which remained distinctly separate from the 
lymphocytes. These patients responded to intradermal lepromin albeit poorly, but 
could be sensitized to DNCB. In l epromatous  leprosy, paracortical areas of lymph 
nodes were heavily infiltrated with foamy histiocytes and the germinal centers 
manifested a hyperplastic plasmacytosis. These patients had a negative lepromin test 
and usually could not be sensitized to DNCB. Thus, this study provides in vivo 
morphological evidence for an association between severity of immunosuppression 
and macrophage infiltration of lymphoid tissues. 
3.5. THE DIFFERENTIAL EFFECT OF MACROPHAGES ON NORMAL VERSUS NEOPLASTIC CELLS 
Keller compared the effects of activated macrophages on normal versus neoplastic 
cells and found that, although both cell types undergo inhibition of proliferation, only 
neoplastic cells were killed (Keller, 1974a, 1976). Evidence supporting the notion that 
only neoplastic cells are killed by macrophages, thus establishing the concept of 
nonspecific but 'selective' macrophage-mediated cytotoxicity, has been provided by 
several laboratories (Currie and Basham, 1975; Cleveland et al., 1974; Hibbs, 1973; 
Holterman et al., 1973; Hibbs et al., 1973; Piessens et al., 1975). All of these studies, 
however, measured target cell lysis rather than target cell proliferation. Our labora- 
tory (Kirchner et al., 1974a, b, 1975) has noted on several occasions that the 
suppressive effect of macrophages on lymphocytes was not observed unless the 
lymphocytes were proliferating rapidly (i.e. stimulated by mitogens, tumor antigens, 
or alloantigens, etc.). One might therefore speculate that some property of trans- 
formed cells which is shared by proliferating lymphocytes but not by resting lym- 
phocytes provides the basis by which macrophages exert their cytolytic and/or 
cytostatic effect. Evidence suggesting that rapidly proliferating cells are more suscep- 
tible to lysis by macrophages than resting cells has been provided by Holterman et al. 
(1975). They have shown that rat embryo fibroblasts are susceptible to cytolytic effects 
only during early passages in tissue culture, when their proliferation rate is high. They 
hypothesized that neoplastic cells may have certain membrane properties in common 
with rapidly proliferating embryonic cells of early passage in vitro which are sub- 
sequently lost through the process of differentiation. Fox et al. (1971) have provided 
evidence that mild proteolytic treatment of normal mouse fibroblasts maintained in 
vitro (3T3) resulted in the appearance of certain agglutinin receptors on the surface of 
the cell membrane which could always be demonstrated on the membrane of polyoma 
virus transformed mouse fibroblasts (Py3T3). The expression of the agglutinin recep- 
tors on the 3T3 cells was associated with an increased rate of proliferation and a loss 
of contact inhibition. The effect was transient, however, and when the proliferation 
rate returned to normal, the agglutinin receptors were no longer demonstrable. 
Although these studies were done with fibroblasts and not with lymphoid cells, they at 
least support the notion that rapidly proliferating cells may express receptors or 
membrane properties normally expressed 'selectively' on continually proliferating 
(transformed) cells. Shinitzky and Inbar (1974) have provided evidence that the 
microviscosity of the surface membrane lipid layer of normal lymphocytes and 
malignant lymphoma cells can be associated with the growth characteristics of the 
cells, and that by altering the microviscosity of the membrane with lecithin-choles- 
terol (1:1) liposomes, one can predictably modify the growth characteristics of the 
cells. These observations further emphasize the possibility that normal cells may 
transiently acquire membrane characteristics of transformed cells during blasto- 
genesis. Thus, if the mechanism by which macrophages lyse transformed cells is the 
same as that mediating cytostasis of both cell types, the ability of lymphocytes to 
cover or fail to express some membrane property when their proliferation is inhibited 
could account for the findings that macrophages have cytostatic effects on both cell 
types but lyse only cells which are transformed. Another entirely possible explanation 
for the findings is that the effector cells involved in the cytolysis are not macrophages 
a t  all but instead are natural killer (NK) cells as recently described by Herberman et 
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al. (1975). Recently Herberman et al. (1977) have shown that many agents with 
well-known RES activating effects strongly boost NK cell activity when administered 
to mice, and that the broad specificity of the cytolytic activity is directed primarily 
toward tumor cells. Similarly, Wolf et al. (1976) observed that i.p. injection of BCG 
caused the appearance of increased cytolytic activity by PEC and that most, if not all, 
of this activity was mediated by NK cells. Our laboratory is currently investigating 
the possibility that at least some of the selective cytolytic effects of PEC previously 
attributed to macrophages may be mediated by highly active NK cells. 
4. CONCLUDING REMARKS 
In this review we have discussed some of the evidence that macrophages provide 
both enhancing and suppressive effects on immune responses. The enhancing effects 
of macrophages might be grouped into three broad categories: prevention of 
tolerance, antigen presentation and enhancing factor production. In the case of 
subcellular protein antigens, macrophages phagocytize and break down much of the 
antigen, thus helping to prevent a prolonged interaction of B cells with high concen- 
trations of free soluble antigen, in the absence of a second signal to produce antibody, 
which would be likely to result in a state of B cell tolerance. Some of the antigen, 
however, is not broken down by macrophages, but instead is expressed on the cell 
surface in a highly immunogenic form. Recent evidence suggests that one form taken 
by such antigen is that of a complex with the MHC antigens on the surface of the 
macrophage. As such, at least T cells can be primed or triggered with the resultant 
generation of helper T cells to provide a second signal to B cells for antibody 
production and/or a clone of highly reactive memory T cells which are then available 
to mediate a vigorous secondary response when presented with the same antigen in 
complex with the same MHC determinant on the surface of a macrophage. In addition 
to presentation of soluble antigens to T cells, there is a wealth of information 
suggesting that macrophages produce factors which can enhance the response of T 
cells to mitogens as well as to cellular antigens such as alloantigens in MLC or 
antigens on the surface of heterologous erythrocytes. More detailed discussion of 
these factors can be found elsewhere in this series. Less is known about the 
macrophage-B cell interaction. There are a number of reports showing that macro- 
phages can stimulate B cells directly to proliferate and produce antibody. In addition, 
there is some evidence that macrophages may play a vital role in mediating T cell-B 
cell collaboration. Further investigations are needed to clarify these issues. 
On the other hand, we have presented evidence that macrophages, if in sufficient 
quantity or if sufficiently activated, can suppress immune responses which are 
dependent on the expansion of a clone of sensitized lymphocytes. Suppression of T 
cell proliferation by.suppressor macrophages in vitro can be correlated with evidence 
obtained in vivo indicating that when macrophages were strongly activated during the 
time when a lymphocyte proliferative response should have occurred, the resultant 
immune state was frequently depressed. Similarly, since suppressor macrophages 
could also suppress B cell proliferative responses in vitro, it is not surprising that 
antibody responses requiring B cell proliferation were frequently suppressed in cases 
where the RES was highly activated such as in chronic graft versus host disease, 
some cases of antigenic competition and in the presence of a rapidly growing 
malignant tumor. 
The suppressive effect of macrophages would seem to be important for several 
reasons. We have discussed evidence that suppressor macrophages could be induced 
by lymphocyte mediators. The best studied mediator apparently capable of inducing 
suppressor macrophages is MIF. In fact, as discussed, it seems likely that many if not 
all suppressor T cells may liberate factors which mediate the suppressor effect 
through macrophages. This then would appear to represent a mechanism by which a 
clonal expansion of sensitized lymphocytes could be slowed or stopped by a product 
of lymphocyte activation. Since 2 or 3 days are required to activate macrophages with 
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lymphocyte mediators (see Section 3.2.4.), such a mechanism would not prevent the 
appearance of a significant number of effector cells and memory cells but could serve 
to limit their continued, excessive production. Such negative feedback systems have 
been described for many regulatory mechanisms in mammalian physiology. As we 
have discussed, suppressor macrophages have little or no suppressor effect on 
cytotoxic T cells or other effector cells which do not proliferate. Thus, established 
immune responses would not be affected through this mechanism. 
In addition, macrophages can be activated to become suppressive by agents which 
may operate through mechanisms independent of lymphocytes. Agents or conditions 
which activate the RES, including the growth of many tumors, have frequently 
resulted in the appearance of splenic suppressor macrophages. Although in this 
review we have concentrated on reports of immunosuppression associated with 
administration of RES activators (C. parvum and BCG), in fact, these agents are 
generally thought of as immunopotentiators. However, a problem with the use of such 
agents is that the immunopotentiating effects are seen inconsistently and, frequently, 
immunosuppression is seen instead. The effects of these agents on the immune 
response in vivo are undoubtedly complex. When used correctly, RES stimulators 
may eventually prove very useful for immunotheraoy. However, when immunosup- 
pression occurs instead of immunopotentiation, it seems likely that suppressor 
macrophages play a role in the suppression. In the case of RES activation in response 
to tumor growth, an interesting situation arises. Although perhaps an appropriate 
response to the tumor, if the RES activation cannot control the growing neoplasm by 
direct cytostatic effects on the tumor cells, it is entirely possible that the resulting 
abundance of suppressor macrophages may play a role in the immunosuppressed state 
frequently observed in cancer patients. There are undoubtedly many ways in which 
tumors can cause immunosuppression. One way, however, might be through a 
mechanism by which tumor cells or tumor cell products lead to an activated RES 
which suppresses immune responses requiring lymphocyte proliferation. In this case, 
however, unlike the response of local macrophages to mediators from sensitized, 
activated, proliferating lymphocytes, the RES stimulus from the tumor might be more 
diffuse, involving a significant proportion of the lymphoid cells. One would predict 
that this would result in a prolonged, nonspecific state of immunosuppression. 
Finally, we have briefly discussed the apparently reproducible observations that, 
although the cytostatic effects of macrophages on rapidly dividing lymphocytes and 
transformed cells seem highly correlative, the 'lytic effects of macrophages' are 
directed selectively toward cells that are neoplastic. Assuming that macrophages are 
indeed the effector cells, we have suggested that the basic recognition process leading 
to the cytostatic and the cytolytic events are similar, and that the selective lysis of 
neoplastic cells reflects the inability of tumor cells to modulate certain surface 
receptors shared by normal lymphocytes only during blastogenesis. 
In summary, macrophages seem to be involved in almost every phase of the 
immune response. They can both enhance and suppress lymphocyte responses, and 
most lymphocyte responses require the presence of macrophages for any of a number 
of reasons to mount any response at all. The observations that suppressor T cells may 
mediate some if not all of their suppressor effects through suppressor macrophages 
help to explain What appeared to be a dual suppressor mechanism triggered by similar 
stimuli but mediated by different effector cells. The evidence discussed in this review 
supports the concept that macrophages play a central role in regulating some aspects 
of the immune response. Hopefully, further investigations of the immunobiology of 
macrophages will enable careful therapeutic intervention via this natural regulatory 
mechanism. 
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